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INVESTIGATIONS OF THE STRUCTURE-FUNCTION RELATIONSHIP IN 
KAINATE RECEPTORS USING FÖRSTER RESONANCE ENERGY TRANSFER 
Abstract 
Douglas Bryan Litwin, M.S. 
 
Advisory Professor: Vasanthi Jayaraman, Ph.D. 
 
 
Kainate receptors belong to the family of ion channels known as the ionotropic 
glutamate receptors. Ionotropic glutamate receptors mediate the majority of 
excitatory synaptic transmission, modulate the release of presynaptic glutamate, and 
facilitate dendrite formation. Kainate receptors are unique among the ionotropic 
glutamate receptors in being modulated by sodium ions. They have also been 
implicated in the development of higher learning and epilepsy. In recent years a 
wealth of structural data has become available for the AMPA and NMDA classes; 
however, the structural characterization of kainate receptors has been limited.  The 
work in this dissertation utilizes luminescence resonance energy transfer (LRET) and 
single molecule Förster Resonance Energy Transfer (smFRET) in order to 
address this gap in the knowledge. We have characterized the structural 
arrangement and dynamics of the homomeric (GluKU) receptors and 
identified structural changes involved in the functional modulation by ions 
and auxiliary proteins. Additionally, we have characterized the arrangement 
and dynamics of the heteromeric (GluKU/GluKd). These data will build a 
ix 
 
foundation for the full biophysical characterization of kainate receptors; and 
contribute to the development of subunit-specific modulatory compounds to 
be used for disease therapies, and for more detailed characterization of brain 
function at the molecular level.   
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Chapter 1: Introduction 
 
Cell signaling with the speed required for the complex physiology found in 
vertebrates is made possible through the modulation of an electrical voltage gradient 
within neurons. These signals are conducted at high speed down neuronal axons 
where they are sent to downstream neurons at junctions called synapses. At the 
synapse, the signal can be electrically relayed between neurons or converted to a 
chemical signal which can then generate an electrical signal in the downstream 
neuron, known as synaptic transmission.  
The voltage gradient utilized for synaptic transmission is created and 
maintained by numerous classes of ion pumps and channels. These channels and 
pumps modulate the voltage gradient by displacing ions in (K+) and out (Na+ and Cl-) 
of the cell which creates net positive charge outside of the neuron.  Synaptic 
transmission can induce both excitatory and inhibitory signals in the receiving 
neuron. Excitatory reception induces depolarization by allowing Na+ back into the cell 
and inhibitory signals induce hyperpolarization by allowing Cl- to reenter the 
postsynaptic membrane or K+ out of the cell. Ionotropic glutamate receptors (iGluRs) 
are the primary carriers of excitatory signaling and Gamma-aminobutyric acid (GABA) 
receptors are the primary carriers of inhibitory signaling in the central nervous system 
(CNS). 
Kainate receptors are members of the iGluR family of ion channels which are 
typically permeable to Na+, K+ and sometimes CaU+. The iGluR family consists of the α-
amino-\-hydroxy-d-methyl-[-isoxazole propionate (AMPA), kainate, and N-methyl-D-
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aspartate (NMDA) receptor subtypes. All subtypes assemble as tetrameric proteins 
composed of a combination of subtype-specific subunits; GluAW-[ for AMPA, GluKW-d 
for kainate, and GluNW-\ for NMDA (W, U). Prior studies have revealed that iGluRs 
function in the reception of excitatory synaptic signaling, the facilitation and 
inhibition of presynaptic GABA and glutamate release, and neuronal dendrite 
formation and growth (U-[). 
Although the exact mechanisms behind cognition, learning and memory are 
not fully resolved, it is well established that iGluRs are critical in these processes. Not 
surprisingly, iGluRs have been implicated in various disease states including 
neurological developmental disorders, schizophrenia, autism, and epilepsy (d, ]). This 
makes iGluRs of particular interest for the development of novel modulatory 
compounds for therapeutic applications. These novel compounds would not only be of 
interest to physicians treating patients affected by neurological disorders but would 
also make it possible for scientists to more accurately study the specific roles of iGluRs 
in the brain. However, attempts to target iGluRs for the therapeutic intervention of 
diseases has yielded little progress due to the ubiquitous integration of iGluR function 
into basal physiological activity. Targeting AMPA, NMDA, and kainate receptors 
individually has consistently been limited by off-target effects resulting from overlap 
in their pharmacological profiles. The solution to this issue is to target not only iGluR 
subtypes but also the different subunit combinations with which subtypes assemble in 
the brain. 
Since the first pharmacological characterization of iGluRs, numerous groups 
have attempted to identify novel iGluR-modulating compounds (f-Wd). However, 
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developing methods capable of high throughput screening potential compounds for 
iGluR modulating activities has been a difficult and time-consuming process. These 
investigations have yielded a number of compounds with high specificity for iGluR 
subtypes, particularly the AMPA and NMDA subtypes, but the majority of these 
compounds have been limited to use in the laboratory. The most promising clinically-
relevant compounds produced have been NMDA antagonists including ketamine, 
memantine, methadone, and dextromethorphan.  
While these compounds have proven useful in certain neuropathies, their 
applications, as with other AMPA and kainate candidate compounds, have been 
limited by unwanted and/or toxic side effects (W]-UV). Therefore, given the success of 
structure-based drug design with other proteins including the NMDA receptor (UW-U\), 
it seems likely that a thorough understanding of the structural conformations and 
solvent-accessible topological chemistries unique to each iGluR subtype will be 
required to allow for the design of compounds with higher subtype specificity. 
Beginning in the early UVVV’s, researchers began resolving the first structural 
models of iGluRs. These studies initially resolved crystal structures of isolated 
extracellular domains and eventually culminated with high-resolution crystallography 
and cryo-EM models of the full-length proteins (U[-\U). The vast majority of the full-
length models available are of AMPA and NMDA receptors with limited structural 
data produced for full-length kainate receptors. These structural models have 
revolutionized our understanding of the mechanics underlying iGluR function. 
However, uncertainties resulting from the static conditions required for X-ray and 
electron-based imaging, and functional data produced that conflicts with structure-
 
4 
 
based interpretations of the dynamic requirements for receptor gating have left many 
unanswered questions concerning the structural characteristics unique to each 
subtype (\\, \[). 
To address this gap in knowledge, the work presented in this dissertation aims 
to examine the dynamic movements and conformational changes involved in full-
length kainate receptor gating and the unique aspects of their functional 
characteristics, including modulation by ions and auxiliary proteins. The FRET data 
presented herein seeks to build on prior knowledge available for the structure-
function relationship in kainate receptors and resolve the structural and dynamic 
properties that give rise to the unique structure-function characteristics of kainate 
receptors. 
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Chapter 2: Kainate Receptor Function and Physiology 
 
Kainic acid (kainate) is a naturally occurring marine toxin produced by certain 
species of seaweed. It was historically known that ingestion of kainate induced severe 
excitotoxic and convulsive responses in mice and humans. In WXf[ the first study 
identifying the excitatory effect of kainate on crayfish muscles was published (\d). 
This study showed that kainate induces excitatory responses in neuromuscular 
junctions that are nearly identical to those induced by glutamate. It was later 
discovered that kainate was acting preferentially on a subtype of glutamate receptor 
that became known as kainate receptors.  
Shortly after the first studies on kainate, it was shown that exposure to alpha-
Amino-\-hydroxy-d-methyl-[-isoxazolepropionic acid (AMPA) produced similar 
excitotoxic effects in animals (\]). The similar physiological responses resulting from 
kainate and AMPA exposure were quickly explained by significant overlap in their 
pharmacological profiles (\f) and this overlap was not found with NMDA class 
receptors. While the pharmacological similarities between the kainate and AMPA 
receptor have made it difficult to resolve the functional characteristics of each 
subtype, distinct and unique functional properties have since been identified for 
kainate receptors.  
It was subsequently shown that iGluRs exist in three functional states: resting, 
active and desensitized. Under resting conditions, the receptor is not bound to agonist 
and non-conductive. Under active conditions the receptor is agonist-bound and 
conducts ions. Under desensitized conditions the receptor is agonist-bound and non-
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conductive. The transitions between these states are described by their activation, 
deactivation, and desensitization and resensitization kinetics. Activation kinetics 
describe the receptors speed of response to agonist.  Deactivation kinetics describe the 
speed of channel inactivation under sub-saturating agonist conditions. 
Desensitization kinetics describe the speed of channel inactivation under saturating 
agonist conditions, and resensitization kinetics describe the speed at which the 
receptors recover from the non-active state. 
On the post-synaptic neuron, kainate and AMPA receptors function to mediate 
the fast component of excitatory synaptic transmission. Both kainate and AMPA 
receptors carry the initial response to presynaptically released glutamate; however, 
kainate receptors typically have a slower activation and prolonged deactivation 
kinetics (U). Additionally, kainate receptors show longer rates of recovery from the 
inactive state. In contrast, NMDA receptors are characterized by a delayed response 
induced by Mg+ blocking the ion channel pore, which requires a prior depolarization 
at the post-synaptic membrane to release (U). These data are not surprising given the 
high primary sequence homology between AMPA and KARs which is significantly 
lower between the two and the NMDAR. 
Studies characterizing the in vivo electrophysiological functions of KARs have 
been limited due to the lack of specific pharmacological compounds; however, the 
development of the U,\-benzodiazepine class of antagonists, which are more selective 
for AMPARs than KARs, made it possible to characterize the synaptic functions of 
KARs for the first time. Using these antagonists it was shown that KARs mediate 
excitatory synaptic transmission in the CAW region of the hippocampus (\Y). 
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Subsequent studies identified their involvement in excitatory synaptic transmission at 
other hippocampal synapses (\X-[W), in the retina ([U), spinal cord ([\), amygdala 
([[), and cortex ([d).  
The most interesting finding resulting from these initial studies was that high 
agonist concentration inhibited presynaptic glutamate release (\Y). These results 
hinted that KARs could be localized and functioning pre-synaptically, which was later 
confirmed by studies showing that KARs are able to inhibit presynaptic glutamate 
release in the neocortex ([]) and cerebellum ([f). The presynaptic roles of KARs were 
expanded when it was shown that KARs can regulate the release of the inhibitory 
neurotransmitter GABA at hippocampal synapses ([Y, [X). Additional studies showed 
that kainate receptors are able to facilitate and inhibit GABA release through 
metabotropic signaling mechanisms ([X, dV). These presynaptic roles of kainate 
receptors are still not fully resolved yet highlight their potential of regulating 
excitatory networks in specific regions of the brain.  
After being cloned and characterized in greater molecular detail, it was shown 
that KARs are tetrameric assemblies of subunits GluKW-d. Each subunit was shown to 
be modular with an amino-terminal domain (ATD), agonist-binding domain (ABD), a 
transmembrane domain (TMD) and a Carboxyl-terminal domain (CTD). While these 
studies confirmed that all iGluR have similar architecture, the structure/function 
relationship of each class remained to be characterized. 
KARs function to produce excitatory post-synaptic currents (EPSCs) with 
different properties through the combination of different subunits in homomeric and 
heteromeric receptors. GluKW-\ function as homomeric or heteromeric assemblies, 
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while GluK[-d require co-expression with either GluKW or GluKU to form functional 
channels (W). The homomeric GluKU receptor has been studied in the greatest detail, 
however, the GluKU/GluKd heteromeric receptors are the most commonly expressed 
KAR in the brain. Interestingly, KAR subunits able to form homomeric channels have 
a significantly lower affinity for glutamate than those that cannot. This has led to 
GluKW-\ being termed low affinity and GluK[-d being termed high affinity KARs. 
 Different functional properties can also be obtained from mRNA editing, 
alternative splicing, and post-translational modifications of the receptors. mRNA 
editing at sites within the transmembrane helices of GluKW and GluKU can result in 
changes of ion permeability (dW). Alternative splicing within the GluKW and GluKU C-
terminal results in endoplasmic reticulum retention of the receptors (dU). 
Phosphorylation of the C-terminal of GluKW results in receptor internalization, while 
phosphorylation of the GluKU C-terminal results in potentiation (U, d\-dd). It is also 
known that SUMOylation of the KAR C-terminal domain can reversibly induce 
receptor internalization. 
While the kainate-mediated EPSCs first found in the CAW region were small in 
amplitude, it was later shown that KARs produce significant currents in the CA\ 
region of the hippocampus and in the cortex ([d, d]). Biochemical, pharmacological, 
and genetic methods have provided some insight into the composition of the KAR 
subunits within these regions. The GluKW-specific agonist U-Amino-\-(\-hydroxy-d-
tert-butylisoxazol-[-yl) propionic acid (ATPA) revealed that the GluKW subunit 
participates in the EPSCs found in the CAW region. Immunohistochemistry studies 
have found that GluKU/GluKd subunits are enriched in the hippocampus and that 
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knockout of either GluKU or GluKd significantly reduces kainate-induced EPSCs in the 
CA\ region of the hippocampus (df, dY).  
Importantly, it has been shown that KARs function in long-term potentiation 
(LTP) and long-term depression (LTD), processes shown to be involved with learning 
and memory formation (dX, ]V). It was shown that blocking presynaptic KARs within 
hippocampal synapses can eliminate LTP (]W) while synapses within the perirhinal 
cortex require KARs for LTD (]U). It was additionally shown that inhibition of KAR-
induced LTP in the agranular insular cortex reduced anxiety behavior in mice (]\). 
Not long after the physiological functions of KARs were first being 
characterized using electrophysiology, KAR knockout models began to be studied. It 
was surprising to find that kainate receptor subunit knockout phenotypes displayed 
no severe somatic defects, with the only effects found involving cognition and 
psychology (df, ][-]X). The behavioral studies performed have shown that GluKW 
knockout mice display reduced cognition and fear response, and increased anxiety 
(][, ]d). GluKU knockout mice display reduced sociability, cognition and fear 
response, an increase in seizures and symptoms of mania (df, ][, ]], ]X). GluK[ 
knockout mice display symptoms associated with depression and mood dysregulation 
and impaired memory formation (]f, ]Y). Knock out of all kainate receptor subunits 
(GluKW-d) resulted in compulsive and perseverative behaviors involving grooming, as 
well as dysfunction in motor functions (fV). 
The lack of severe somatic defects in kainate receptor subunit knockout mice 
initially led to limited interest and even questioning of their physiological relevance. 
However, mRNA expression profiles of iGluRs in the brain showed that while each 
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iGluR subtype has its own unique expression patterns, kainate receptors show 
enrichment in areas important for learning, behavior, and anxiety (fW). Additionally, a 
recent study identified a gain-in-function mutation in GluKU that causes severe 
neurodevelopmental delay and intellectual disability (fU). These results corroborated 
the phenotypes of the knockout models. 
The abundance of kainate receptors in these areas, combined with their mild 
knockout phenotypes and varied functional roles, might position them as the most 
ideal iGluR subtype for the treatment of neurological disorders, particularly 
psychiatric and psychological disorders. However, progress on this front will require 
drugs with the specificity necessary to discriminate between kainate receptors in their 
various functional roles. 
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Chapter 3: Functional Modulation of Kainate Receptors 
 
Auxiliary proteins 
Through their initial functional characterization, it was discovered that kainate 
receptors produced currents in heterologous expression systems that differed 
significantly from kainate receptor currents recorded in native tissue. Kainate 
receptors expressed in heterologous systems showed rapid activation and deactivation 
kinetics, while currents recorded in tissue showed rapid activation with prolonged 
deactivation kinetics (f\, f[). The mechanisms contributing to these differences were 
initially a mystery. However, since that time it has been well established that iGluRs 
associate with a number of post-synaptic membrane proteins that alter their 
localization and function (fd-ff).  
Function-modulating auxiliary proteins have since been discovered for AMPA 
and kainate receptors; there are six Transmembrane AMPA receptor Regulatory 
Proteins (TARPs) and a Germ cell-Specific Gene W-Like (GSGWL) protein for AMPA 
receptors and NetoW and NetoU proteins for kainate receptors (ff-fX). Currently no 
auxiliary proteins are believed to be NMDA receptor-specific. Neto1 was initially 
thought to modulate NMDA receptors (YV), but was later shown to be specific to 
kainate receptors (YW). NetoU was discovered through co-immunoprecipitation 
experiments and was found to increase the function by delaying the onset of 
deactivation in kainate receptors (ff).  
The functional effects of NetoW and NetoU on kainate receptors have been 
extensively tested in heterologous systems and show a gain in function that varies 
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according to the kainate receptor subunit composition (ff, YW-Y\) (Y[). The gain in 
function induced by Neto co-expression results in kinetics with delayed onset of 
deactivation and desensitization. These currents behave more similarly to currents 
obtained from tissues. These studies have refined our understanding of the in vivo 
functional properties attributed to kainate receptors, but it is worth noting that 
studies on kainate receptors in tissue are hampered by the difficulty of isolating AMPA 
receptor and kainate receptor currents. This is an area that would specifically benefit 
from advances in iGluR-modulating compounds that have high specificity. 
Currently the structure of Neto proteins has not been solved. It has been 
shown biochemically that both Neto proteins consist of two N-terminal extracellular 
complement subcomponents Clr/Cls, Uegf, BmpW (CUB) domains followed by a low-
density lipoprotein (LDL)-like domain, a transmembrane region, and a C-terminal 
intracellular domain. Studies have shown that the CUB and LDL domains are involved 
in the modulation of kainate receptors and that the second CUB domain is the most 
influential on receptor function (YW, Yd). The transmembrane region is believed to 
contribute stability to the Neto-kainate receptor interaction and the C-terminal is 
known to be involved in trafficking (Y]).  
While there are no structural data available for Neto proteins, there are a 
number of studies characterizing the structure of other CUB- and LDL-containing 
proteins (Yf-Xf). These studies have shown that, W) CUB domains consist of anti-
parallel beta sheets with conserved disulfide bridges and a conserved tyrosine-
glutamic acid-aspartic acid-aspartic acid (YEDD) motif, and U) CUB domains mediate 
a variety of protein-protein interactions that are amongst classes of proteins that are 
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important for developmental regulation. The acidic YEDD motif has been shown to be 
the mediator of protein-protein interactions in a variety of other proteins and likely 
binds to a basic pocket within the agonist-binding domain or transmembrane linker 
regions of the kainate receptor. A similar acidic motif has been identified for AMPA 
auxiliary proteins (XY, XX). 
While the majority of our current understanding of the structure of Neto 
proteins is derived from studies performed on homologous proteins, a coherent 
picture of the structure-function relationship can be conceptualized. The functional 
data currently available for Neto protein truncations make it clear that like other 
homologous proteins, Neto modulation is mediated by extracellular CUB domain 
interactions. However, the full structure-function relationship between kainate 
receptors and Neto proteins cannot be fully resolved until high-resolution structural 
models of the receptor complex are available. 
 
Monovalent ions 
iGluRs are known to be functionally sensitive to extracellular ion 
concentration. NMDA receptors are inhibited by zinc (WVV, WVW),  while AMPA and 
kainate receptors can be inhibited or potentiated by divalent ions such as calcium, 
barium, magnesium, and zinc (WVU-WVX). However, kainate receptors are unique by 
being modulated by the monovalent ions sodium and chloride (fY, WWV-WWd). 
The effects of sodium modulation have been well characterized in the 
homomeric GluKU receptor with very few studies reported on heteromeric kainate 
receptors. It has been thoroughly shown that GluKU homomeric receptors require WdV 
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mM NaCl for glutamate-induced currents and replacement with other monovalent 
cations like Cs+ nullifies function, reducing currents by YV-XV% as compared to Na+-
containing currents (WW]). Heteromeric GluKU/GluKd receptors are also sensitive to 
CsCl replacement although to a lesser degree with currents reduced by ]d-fd% (WW]). 
Molecular dynamic simulations suggest that it is the displacement of the Na+ ion from 
the ABD dimer interface that initiates transition from the active to desensitized state 
(WWf). Additionally, it has been shown that co-expression of NetoU with both 
homomeric and heteromeric receptors reduces their sensitivity to cations. Co-
expression with homomeric GluKU showed a ]\% reduction in currents and 
heteromeric GluKU/GluKd showed a []% reduction in current, as compared to their 
corresponding Na+ currents (WWY). 
There are now many studies characterizing the ion sensitivity of KARs in 
heterologous systems and precious few on native receptors. However, these studies 
have established that homomeric, heteromeric, and auxiliary protein-associated 
kainate receptors all require WdV mM Na+ ions in order to exhibit a normal response to 
glutamate. Additionally, it has been shown that cultured hippocampal cells (WW]) 
display kainate receptor-mediated ion sensitivity and that the concentration of 
sodium ions in the synaptic cleft is predicted to drop by as much as [V mM during 
normal synaptic transmission (WWX). Therefore, it is hypothesized that the sensitivity of 
kainate receptors to synaptic sodium concentration would act as a feedback 
mechanism in which reduced synaptic sodium levels in an overactive synapse would 
cause the kainate receptors to become unresponsive to glutamate release (WWd). 
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Unfortunately, this hypothesis will be difficult to test in native systems, however, a 
mechanism of this nature should not be discounted. 
There are now several converging lines of abductive evidence for a 
physiological role involving the modulation of KARs by ions. First, mathematical 
modeling of the ion flux during normal synaptic activation produced a conservative 
estimate of a [V mM decrease in Na+ concentration (WWX). This would place the affinity 
of KARs for Na+ within the dynamic range of ion flux at the synapse. Second, it is 
unlikely that a relationship of this nature would be retained throughout evolution 
without conferring some kind of advantage to the animal’s phenotype. Third, there are 
several other classes of channels and receptors that functionally respond to flux in Na+ 
ion concentration on either the extra- or intercellular membrane (WUV-WU\). Therefore, 
it seems plausible that future experiments will show that the dependence of KARs on 
Na+ concentration is a mechanism which adds to the complexity found in the systems 
regulating excitatory signaling at certain synapses. 
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Chapter 4: Kainate Receptor Structure 
 
Kainate receptors, like all iGluRs, are tetrameric proteins with each subunit 
comprising two large extracellular domains, a transmembrane channel and 
intercellular C-terminal domain (Figure I). They form functional homomeric and 
heteromeric proteins, although the most commonly expressed KARs are heteromeric. 
Based on photobleaching and crystallography studies of the isolated ATDs, the 
stoichiometry of heteromeric GluKU/Kd KARs is believed to be U:U with GluKU 
mediating ATD dimer-dimer interactions (WU[, WUd). 
Each subunit is composed of domains that are modular in architecture and are 
structurally and functionally distinct: the extracellular amino-terminal domain (ATD), 
the extracellular agonist-binding domain (ABD), the transmembrane domain (TMD), 
and the intracellular carboxyl-terminal domain (CTD). A unique architectural 
characteristic of iGluRs is termed domain swapping, which involves asymmetry in 
which subunits associate within the ATD and ABD dimer pairs (Figure I). Linker 
regions connect the ATD to the ABD, and the ABD to the TMD. The structure and 
function of the individual domains will be discussed in greater detail below. 
 
Amino-terminal domain 
 The ATDs of the kainate receptor are positioned above the ABDs on the 
extracellular side of the membrane (Figure I). They are preceded in the open reading 
frame only by a membrane localization peptide signal sequence. These are the largest  
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Figure 1. Structural model of the homomeric GluK2 receptor. 
(A) Architecture of the GluKU primary sequence. (B) The homomeric kainate receptor 
shown under glutamate-bound conditions with each subunit individually colored. The 
modular domains are labeled, and the carboxyl-terminal domain is not shown as it has 
not yet been resolved. The image is derived from PDB:5KUF resolved using cryo-EM 
(29). 
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domains within the KAR and have the most diversity in primary sequence (WU]); 
however, their functional roles have been difficult to resolve.  
Several studies have shown that the individual KAR ATDs are arranged as bi-
lobed clamshell-like structures composed of an RW upper lobe and RU lower lobe (U], 
UX). These subunits assemble into dimers to form the dimer of dimer architecture 
found in all iGluRs. The similarities of the ATDs to metabotropic glutamate receptor 
agonist-binding domains initially left researchers looking for additional ATD specific 
ligands; however, no ATD specific modulating ligands have been found for KARs. 
While ATD allosteric modulation of receptor function has been shown in the 
NMDAR, no allosteric role has been shown for KARs or AMPARs. This led to the idea 
that the main role of the ATD involves the initiation of assembly and likely determines 
the subunit arrangement of the receptor.  This was supported by many studies 
showing that the affinities of the various subunit ATD dimers coincide with the 
combinations of subunits that form functional channels (WUf-WUX), and studies 
showing which subunits likely mediate heteromeric KAR ATD dimerization (WUd). 
While these data support the role of ATDs in receptor assembly, it has also been 
shown that complete deletion of the ATD in both KARs, AMPARs and NMDARs has 
no effect on receptor assembly or function in heterologous systems (W\V, W\W). This 
would suggest a different primary role for the ATD in receptor function. 
Following these initial studies, functional roles were identified for KAR ATDs 
involving receptor and auxiliary subunit localization. Studies have shown that while 
GluKU subunits localize to the membrane independent of auxiliary proteins, the 
surface expression of auxiliary proteins NetoW and NetoU depend on GluKU ATD-Neto 
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interactions (Y]). Additionally, GluKW shows an ATD dependent increase in surface 
expression in the presence of NetoW and NetoU (W\U). This suggests that KAR ATDs are 
associating with Neto proteins and that interaction can direct receptor and auxiliary 
protein localization. Interestingly, the localization of GluKW can also be affected by the 
membrane signal sequence even after being cleaved (W\\). These data point to the role 
of ATDs in receptor and auxiliary protein localization; however, it is possible that 
additional roles remain to be characterized. 
 While structural studies of the isolated ATDs have shown that KAR ATDs have 
a similar architecture as the closely related AMPARs, differences were found when full 
length receptor models became available. While both the AMPA and kainate receptor 
showed a compact and coupled arrangement between ATD dimer pairs in the apo 
state, three classes of arrangements were observed in the glutamate-bound state of the 
AMPAR with varying degrees of decoupling between the ATD dimer pairs (U]). This 
decoupling was not found in the full-length KAR models of the glutamate-bound state 
(U], UX). The glutamate-bound state KAR models showed only small ATD rotations 
relative to the antagonist-bound state. The AMPA ATD decoupling has since been 
confirmed with smFRET studies (W\[); however, currently there are no complementary 
studies available characterizing the conformational dynamics of KAR ATDs in the full-
length receptor.  
 
Agonist-binding domain 
 The agonist binding domain resides between the ATD and the TMDs in the 
extracellular space (Figure I). As described by name, the ABD is responsible for 
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binding agonists and initiating the process of activation. It is connected to the ATD 
and TMD layers through linker regions that, in the case of the TMD, transfer 
conformational changes to the pore region to activate the channel. It was shown 
biochemically that the interface within the ABD dimer pairs plays a significant role in 
receptor kinetics, but it took full length iGluR models to identify what the structural 
implications of this interface involve. While it is now believed that decoupling 
between the dimer pairs is the driver of the desensitization process, there have been 
studies that question the nature of the decoupling needed for receptor function (\\). 
 The ABD maintains the highest degree of primary sequence homology among 
the iGluR subtypes and the glutamate coordinating residues are maintained between 
all three classes, R[XU, T]dX and EdVf in GluKU. Similar to the ATD, the ABD is 
arranged in a bi-lobed configuration. The ABD architecture resembles a clamshell with 
a cleft that clamps down on agonists, leading to closure of the cleft. The ABD is 
composed of two peptide segments within the primary structure named SW and SU. The 
SW segment connects with the ATD and terminates at the first transmembrane helix 
while the SU segment is positioned between two of the transmembrane helices. The 
tertiary folding structure of the SW and SU segments results in an upper DW and lower 
DU lobe that comprise the clamshell structure. 
 
 
Structural studies initially characterized the isolated ABDs of the various KAR 
subtypes which gave valuable insight into their role in receptor gating. These studies 
showed that different ligands impose varying degrees of cleft closure in the different 
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subunits that correlate with their efficacy (W\d-W[V). Subsequent studies using LRET 
and smFRET on the all three receptor subtypes confirmed the agonist induced cleft 
closure (W[W). These studies also identified the sites responsible for the ion sensitivity 
found in KARs. 
 Studies characterizing the isolated ABD of GluKW and GluKU using X-ray 
crystallography identified a Na+ binding pocket driven by atomic interactions between 
the Na+ ion and residues QdVX and KdW] (WW\). Not surprisingly, this pocket was found 
to reside at the ABD dimer interface and highlights the importance of this interface. 
Subsequent molecular dynamic simulations showed that the unbinding of Na+ from 
this pocket likely induces the desensitization process in KARs, and that with Na+ 
present significantly more energy is required to separate ABD dimers (WWf, W[U). 
 The importance of the ABD dimer interface was further highlighted by separate 
studies characterizing the effect of varying mutations within the dimer interface of 
GluKU. These studies identified point mutations that both delayed (W[\) and 
eliminated desensitization (W[[). Most importantly, they showed that introduction of 
a positively charged lysine residue at site Dff] in GluKU induced constitutive activity 
in the receptor. These were intriguing results that were later hypothesized to further 
explain Na+ sensitivity in KARs. Later, MD simulations showed that the lysine 
introduced at position ff] can potentially occupy the Na+ binding pocket and confer 
stability between the dimer pairs that prevent decoupling, and entrance into the 
desensitized state (WWf). 
 Importantly, the structural arrangement of the ABD as determined using 
isolated domains was subsequently verified by full-length structures of the AMPA, 
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kainate and NMDA receptor. However, while there has been a plethora of full-length 
receptor models produced for the AMPA and NMDA classes, full-length kainate 
receptor models have been difficult to obtain. To date there is a single PDB deposited 
in the Research Collaboratory for Structural Bioinformatics (RCSB) structural database 
for the antagonist-bound state and two PBD deposited for the agonist-bound state 
(U], UX). The antagonist-bound studies could only produce a low resolution (UW Å) 
electron density map in which previously resolved crystal structures of the isolated 
ABD were fit (UX).  The two agonist-bound models are nearly identical showing full 
decoupling of the ABD dimers, moving to almost four-fold symmetry within the ABDs. 
 These structures confirmed many previous findings and have collectively been 
used to construct models for the gating mechanism of iGluRs. It is believed that 
binding of agonist induces cleft closure at the ABD, which causes strain on the TMD 
linkers, leading to channel activation. Once activated, the dimer interface within the 
ABD dimers maintains the open channel conformation until that interface gives way 
and decouples; KARs being unique in requiring the unbinding of ions for decoupling 
to proceed.  Once the ABDs decouple, the strain is relieved from the TMDs and the 
channel closes, leading to desensitization. 
 As previously mentioned, the decoupling process is now believed to be the 
mechanism initiating desensitization. There is clear evidence for this being the case; 
however, structural models of the full-length AMPA and KARs have shown vastly 
different conformations under desensitized conditions. Studies of the homomeric 
GluAU show three classes of desensitized conformation with varying degrees of 
decoupling (U]). Additionally, a study characterizing the effect of crosslinks made 
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between AMPAR ABD dimers showed that decoupling is not required for normal 
receptor function (\\).  
 Therefore, the question of decoupling and the conformations that the KAR 
ABDs occupy in various conditions remains unclear. The apo state full length models 
leave assumptions about dynamics resulting from low resolution electron densities, 
while the agonist-bound state differs significantly from agonist-bound AMPA 
structures. These questions will be further addressed in this dissertation. 
 
Transmembrane domain 
The transmembrane domains of iGluRs are responsible for forming the channel 
pore in which ions flow and conferring selectivity to which ions are allowed to pass 
through the pore. Before detailed iGluR structural models of became available, their 
transmembrane topology was predicted using classical biochemical techniques with 
remarkable precision. These studies used glycosylation and protease protection assays 
to determine that despite there being four TM regions predicted from analysis of 
iGluR primary sequence, there were likely only three transmembrane helices in the 
mature protein (W[d, W[]). These findings were later confirmed by structural models. 
Structural models of the AMPAR first showed that the TMDs are composed of 
three transmembrane helices, MW, M\ and M[, and one membrane reentrant loop MU. 
The architecture of the TMD is arranged in pseudo four-fold symmetry and have high 
primary sequence homology with both K+ channels and bacterial GluRV K+ selective 
channels (U). The transmembrane helices anchor the receptor to the membrane and 
play a critical role in channel function.  
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The pore is formed by the MU loop, lining the inner cavity, while the M\ helix 
line the outer pore cavity (U[). The apex of the MU reentrant loop harbors residue 
QdXV which is known to be commonly RNA edited to an arginine residue. RNA 
editing at this cite renders the channels impermeable to CaU+ ions, which is critical for 
CaU+ induced intercellular signaling mechanisms (W[f). The MW helix runs exterior to 
the pore forming MU loop and M\ helix and is likely key structural support, although 
mutations with the M\ helix have been found that effect receptor function and cause 
intellectual impairment (fU). Surprisingly, the intracellular loop connecting the MU 
loop and M\ helix in the GluKd subunit has been shown to contain a trafficking signal 
that retains the receptor in the ER (W[Y). The MW and M\ helix with the MU loop forms 
the channel domain and this architecture is well conserved through evolution (U[). 
The M[ helix lies peripheral to the pore domain and is unique to eukaryotic 
glutamate receptors (U[, W[X). It encases the pore domain and interacts with the M\ 
helix of adjacent subunits. Given its recent appearance in evolution, the function of 
the M[ helix has been of interest; however, studies of the M[ helix in AMPA and 
NMDA have shown mixed results. It was shown that in the AMPA receptor the M[ 
helix is involved only in receptor assembly, while it is not critical for assembly in 
NMDA but shows effects on gating kinetics (W[X). Currently no studies are available 
characterizing the M[ helix in KARs directly. 
While the role of the TMD in channel pore formation seems straight forward, 
studies have also found that the linker regions connecting the M\ helix to the ABD are 
critical in modulation by Neto proteins. These studies found residues in this linker 
region that when mutated either attenuate or abolish Neto modulation and reduce the 
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ion sensitivity of both homomeric and heteromeric KARs (WWY). These data suggest a 
significant role for the M\ linker in auxiliary protein modulation and it is likely that 
the TMDs play additional roles in the KAR-Neto interaction; however, further studies 
will be required to fully resolve the mechanism of interaction and modulation for Neto 
proteins. 
 
C-terminal domain 
The C-terminal domain has been the most difficult to resolve structurally 
among all iGluRs. Due to high structural dynamics, it has not been fully resolved using 
imaging techniques. It is classified as a disordered region that mediates protein-
protein interactions, receptor localization and can modulate function through post-
translational modifications. 
Similar to the ATD, trafficking and localization roles have been identified for 
the C-terminal domain. It is now understood that alternative splicing and post-
translational modifications are able to affect the subcellular localization of KARs. It 
has been shown that GluKU harbors a motif of basic amino acids (CQRRLKH) within 
the C-terminal domain that allows for exit from the endoplasmic reticulum (WdV), and 
GluKd harbors a similar basic motif (RRRRR) that promotes retention in the ER (WdW). 
It is known that the CTDs of KARs are commonly modified through alternative RNA 
splicing which can either add or remove these trafficking motifs; therefore, it is 
believed that alternative splicing regulates the surface localization of KARs in different 
brain regions. 
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The effects of the CTD on receptor localization were also highlighted by 
studies showing that palmitoylation, phosphorylation and SUMOylation effect 
receptor surface expression. Palmitoylation of the GluKU C-terminal domain at CYdY 
and CYfW promotes surface localization of the receptor (WdU). Phosphorylation of 
serines YfX and YYd on the GluKU and GluK\ C-terminal domain reduces surface 
localization of the receptors. It was additionally shown that SUMOylation of GluKU 
KYY] can reversibly mediate GluKU surface localization (Wd\). 
The CTD has been shown to regulate receptor localization though a variety of 
protein-protein interactions. It has been well established that the CTD mediates 
interactions important for localization, post-translational modification and receptor 
kinetics including but not limited to: CASK, GRIP, GRIPU, mLIN-WV, PICKW, PSDXd 
SAPXf, Shank\, Syntenin, Actinfilin, Contactin, Dynamin-W, Dynamitin,  Profilin, 
SUMO, and Calmodulin (U). 
Phosphorylation sites within the C-terminal domain have also been found that 
directly affect KAR function. Phosphorylation at serines YUd and Y\f on GluKU results 
in potentiation of receptor currents (U). Phosphorylation of site YdXV on GluKU results 
in potentiation and increased KAR mediated intercellular CaU+ signaling (Wd[). 
Additional phosphorylation sites have been found on GluKW, GluKU and GluK[; 
however, testing the functional effects remains to be done. 
The structural conformations and dynamics that produce the unique 
functional characteristics previously described in the scientific literature for KARs will 
be more closely examined in the following chapters. 
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Chapter 5: Förster Resonance Energy Transfer in Structural Biology 
 
This chapter is based upon research originally published in Methods in 
Molecular Biology. Litwin, D. B., R. J. Durham, and V. Jayaraman. Single-molecule 
FRET methods to study glutamate receptors. Methods in Molecular Biology -Glutamate 
Receptors. Humana Press. UVWY; WX[W: \-W] © Springer Nature Switzerland AG. 
 
The first biological X-ray crystallography experiments characterizing 
myoglobin and hemoglobin not only opened our eyes to the relation of function and 
form in biology, but also revealed the utility of structural biology for studying the 
evolutionary origins of proteins and for designing useful drugs. X-ray crystallography 
and cryo-electron microscopy have since emerged as the front runners in the field of 
structural biology and have provided new insight into all fields of biological science. 
These techniques will without question continue to lead the way in structural biology. 
They both, however, suffer from the limitation that they lack the ability to provide the 
complete structural landscape, dynamics in terms of transitions between states and 
energetics of transitions between states. This limitation in current methods has 
created a niche for studying the structure of unresolvable molecules in addition to 
validating and studying the true dynamics of previously resolved X-ray and cryo-EM 
models (Wdd, Wd]). Fluorescent spectroscopy, including Luminescence Resonance 
Energy Transfer (LRET) and single-molecule fluorescent resonance energy transfer 
(smFRET), have emerged as the leading methods for this role (W\[, Wdf, WdY). 
 
28 
 
smFRET has become of particular interest to groups studying highly dynamic 
proteins and proteins composed of multiple domains acting in concert to perform 
mechanically complex motions. Initial efforts have focused on characterizing the 
structure of DNA/RNA molecules, DNA/RNA protein complexes, enzymes, signaling 
proteins, and ion channels (W\[, Wdf-Wf[). LRET is a complementary FRET method 
useful for characterizing large scale conformational arrangements of proteins near 
native conditions. iGluRs are a family of ion channels that serve as a perfect subject for 
smFRET and LRET studies (W\[, Wdd-WdY, W][, WfV). iGluRs are multimeric, have four 
domains with little functional overlap, operate with millisecond kinetics, and have 
previously-resolved X-ray and cyro-EM models.  
iGluRs are tetrameric proteins with two extracellular domains, a 
transmembrane domain (TMD), and an intercellular C-terminal domain. iGluRs are 
divided by their selective agonists into AMPA, kainate, and NMDA subgroups, and 
some subgroups can express as homomers or heteromers depending on the subunits 
used. The extracellular amino terminal domain (NTD) and ligand binding domain 
(LBD) are of particular interest for smFRET studies due to the complex 
rearrangements proposed during the operation of the protein. smFRET and LRET are 
complementary techniques where LRET is able to monitor the average distance 
between two fluorophores in an ensemble of molecules and smFRET is able to 
characterize the distance and changes in distance at a single molecule level. In this 
chapter we will discuss the approach to and execution of smFRET and LRET to study 
the conformational dynamics of iGluRs. 
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Förster resonance energy transfer 
Förster (or fluorescent) resonance energy transfer (FRET) is a term describing 
the non-radiative transfer of energy from a donor fluorophore to an acceptor 
fluorophore. This relay of energy relies on the overlap of the donor and acceptor 
spectra, specifically that the emission of the donor overlaps with the excitation of the 
acceptor as seen in Figure T.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Excitation and emission spectrum of Alexa 555 and Alexa 647. 
Spectral data for the excitation (Dotted) and emission (Solid) wavelengths of Alexa 555 
(Green) and Alexa 647 (Red). 
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This phenomenon is distance-dependent where the closer the fluorophore 
pairs are in space the more likely they are to FRET. The efficiency of energy transfer is 
related to the inter-dye distance (RDA) and the distance of half-maximal energy 
transfer for a given fluorophore set (RI), as seen in equation W. The effective distance of 
FRET for fluorophores ranges between WV and WVV Angstroms, making FRET ideal for 
measuring distances at the protein level.  
 
𝑬 =
𝟏
𝟏 + (𝑹𝑫𝑨 𝑹𝟎⁄ )𝟔
 
Eq. W 
 
When choosing a fluorophore pair for a FRET experiment the most important 
factors to consider are the distance intended to be measured and the RI of the 
fluorophore pair. The factors contributing to the RI of a fluorophore pair are the 
orientation factor, k; the quantum yield of the donor, ΦD; the spectral overlap integral, 
J; and the refractive index of the media, n. The relationship between these values and 
the RI is shown in equation U. There are many detailed reviews on the physics of FRET 
if additional information is needed (Wfd).  
 
𝑹𝟎 = -
𝟖. 𝟕𝟖𝟓	 ×	𝟏𝟎𝟓 ×	𝒌𝟐 ×	𝜱𝑫 × 	𝑱
𝒏𝟒 :
𝟏
𝟔;
 
Eq. U 
 
 
 
31 
 
Luminescence resonance energy transfer  
LRET is a FRET based technique adapted to utilize organic fluorophores 
attached to chosen sites within a protein. The measurement is conducted on a 
population of molecules, typically still retained within the cell membrane, while the 
sample is kept near native temperature and ionic strength. The disadvantage of LRET, 
similar to traditional FRET experiments, is that a measurement is made on a large 
population of molecules and the signal obtained is an ensemble their collective 
behavior. This is useful when looking at large protein movements and proximity; 
however, these measurements provide an ensemble average and the complete 
structural landscape along with transitions between the states cannot be resolved. 
 
Single-molecule Förster resonance energy transfer 
In order to circumvent the previously mentioned limitations of traditional 
FRET and LRET experiments, total internal reflection microscopy (TIRF), U-photon 
excitation microscopy, and confocal microscopy have been adopted to bring 
measurements to the single molecule level of both immobilized and freely diffusing 
molecules as well as in living cells.  
These advantages of smFRET have vastly improved our ability to characterize 
sub-millisecond dynamics in protein, DNA, and RNA in addition to resolving protein 
subunit stoichiometry. However, collecting data with such detail does not come 
without its caveats. Data analysis has become the most difficult part of smFRET and 
methods for collecting and analyzing data have had to evolve. The advent of 
multiparameter fluorescence detection (MFD), time correlated single photon counting 
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(TCSPC), pulsed interleaved excitation (PIE), and fluorescence correlation 
spectroscopy (FCS) have vastly improved the potential quality of smFRET data, 
discussed further in the data analysis section. Instruments capable of collecting data 
using MFD, FCS, PIE and TCSPC simultaneously are now available. The collective use 
of these techniques has greatly improved our ability to resolve the inherent 
complications of fluorophore photophysics and movements from true FRET signal 
(Wf]). In this chapter we will focus smFRET and LRET measurements using confocal 
imaging and lifetime-based measurements respectively. 
 
Experimental design 
The design of LRET and smFRET experiments are similar. Any requirement 
unique to one or the other will be noted. When designing a LRET or smFRET 
experiment studying iGluRs, the labeling strategy used will depend on the subunit 
being studied and the intended measurement. The main design step is site selection 
and considerations here will be the subunit arrangement, distance to be measured, 
and fluorophore pairs. 
In a heteromeric iGluR such as the NMDA receptor there will be two sets of the 
subunits arranged in a defined orientation. By taking this into account it is possible to 
pick a surface-exposed amino acid position on either of the subunits used that is V.d-
WX the RI of the fluorophore pair. In this case labeling with a site-specific cysteine is 
recommended. For example, in Figure W the heteromeric NMDA receptor is shown 
with transmembrane residues selected to measure the change in distance across the 
axis of the pore. Only the highlighted residues will be labelled and measured.  
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Figure 3. Model of the NMDA receptor showing an ideal FRET measurement   
in a heteromeric receptor. 
A structural model of the NMDA receptor showing phenylalanine 554 (Red) as the 
fluorescent labeling site for measurements across the ion pore (PDB:5UP2) (27), side 
view (left) and top view (right). 
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If using a homomeric iGluR such as in homomeric AMPA receptors, choosing 
sites for study could be more complicated. This is the result of having the site of 
interest on all four subunits. In this case, it is required that the site of interest has one 
high FRET distance V.d-WX the RI and one distance ideally well above the RI of the 
fluorophore pair for a given state. As seen in Figure Y, the site chosen will have a 
primary FRET distance of [W Å with an additional distance of ][ Å across dimer pairs. 
This ensures that the main FRET component, [W Å, is V.d-WX the RI and will be easily 
resolved from the longer component. In this chapter we will focus on the use of 
heteromeric iGluRs.  
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Figure 4. Model of the AMPA receptor showing an ideal FRET measurement in a 
homomeric receptor. 
A structural model of the AMPA receptor showing aspartic acid 473 (Red) as the 
fluorescent labeling site for measurements between the LBDs (PDB:5VHZ) (28), side 
view (left) and top view (right). 
 
 
 
 
 
36 
 
When studying iGluRs using smFRET, immobilizing the protein on slide via 
antibody pull-down is preferred. Any antibody with high specificity will work; it is 
recommended, however, to introduce an affinity tag at the C-terminus to minimize 
the effect of antibody binding on protein function. When using a new antibody it is 
critical to run western blots to confirm specificity of the antibody. When performing 
LRET, antibodies are only required for validation of expression. 
 
Cysteine labeling 
The best option for fluorophore labeling for both LRET and smFRET is by 
introducing a cysteine at the site of interest. This allows use of many commonly 
available thiol-reactive fluorophores and retains high expression levels. This does 
however require that all the native non-disulfide bonded cysteines be mutated to 
provide a clean background. Once this is achieved, the expression and function of the 
cysteine-less construct must be verified. When approaching the design of an 
experiment it is ideal that one choose sites that will show a change in distance and will 
also have one effective FRET distance. It is not always possible to achieve the ideal 
labeling strategy in every region of the protein, or the measurement may need to be 
made within the subunit itself. If either of these is the case, utilizing unnatural amino 
acids allows for additional site specific labeling.  
 
Unnatural amino acid labeling 
Unnatural amino acids are advantageous in that one retains the native coding 
sequence of the protein; however additional plasmids must be maintained for use and 
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expression of the protein needs to be verified by western blotting and function of the 
protein verified. The principle behind utilizing unnatural amino acids is using a tRNA 
and aminoacyl-tRNA synthetase that have been artificially evolved to suppress the 
amber stop codon (TAG). The TAG can be inserted by mutagenesis into any position 
along the protein and, when co-transfected with plasmids containing the tRNA and 
aminoacyl-tRNA synthetase, will be suppressed by the incorporation of the unnatural 
amino acid into the peptide chain (Wff). 
 
LRET sample preparation 
HEK293T cells are transiently transfected according to manufacture’s protocol and 
maintained in DMEM. The transfected cells are collected and washed three times in 
extracellular buffer containing 160 mM NaCl, 1.8 mM MgCl2, 1 mM CaCl2, 3 mM KCl, 
10 mM glucose, and 10 mM HEPES (pH 7.4). The washed HEK cells are then labeled 
with 400 nM donor and 100 nM acceptor fluorophores in 3 ml extracellular buffer, 
rotating at room temperature in the dark for 1 hr. The donor fluorophore typically 
used is terbium chelate (Invitrogen), and the acceptor fluorophore used is fluorescein 
maleimide (Thermo Fisher Scientific), for cysteine mutants. After labeling, cells are 
washed and resuspended in 2 ml extracellular buffer and are ready for use in LRET 
measurements.  
 
Data collection LRET 
A cuvette-based system consisting of a fluorescence lifetime instrument (EasyLife 
L;Hoiba) and analysis software (Fluorescan 5.5; Optical building blocks) is needed for 
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LRET measurements. Samples should be excited at 337 nm when using terbium 
chelate. Emission is detected at 545 nm for donor-only samples, at 515 nm for 
fluorescein-labeled samples. LRET measurements should be taken in triplicate for a 
given condition followed by scans after Factor Xa protease cleavage to quantitate the 
samples’ background signals without the labeled receptors’ contribution to the signal.  
 
Data analysis LRET 
Fluorescent decay plots obtained for given conditions and the background for 
that condition should be plotted in graphing software like Origin (OriginLab) and 
averaged, and then the background can be subtracted from the full signal. Following 
background subtraction, the resulting decay plots are fit to exponential decay 
functions thereby quantitating the decay lifetime of the acceptor fluorophore. Error in 
the distance estimates is calculated by propagating the errors in the donor and 
acceptor lifetimes using the Error Propagation Calculator developed by Thomas Huber 
in the Physics Department of Gustavus Adolphus College. Lifetimes should also be 
quantitated for samples labeled with only the donor (tD) and samples labeled with 
both donor and acceptor (tDA), to be used to calculate the distance between the 
fluorophores using the Forster equation: 
 
𝑹 = 𝑹𝟎(
t𝑫𝑨
	t𝑫 − t𝑫𝑨
)𝟏 𝟔;  
Eq. 3 
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where R is the distance between donor and acceptor fluorophore, R0 is the distance 
yielding half-maximal energy transfer for a given fluorophore pair (45 Å  for terbium-
fluorescein), tD is the measured lifetime of the donor when bound to the protein and 
without acceptor fluorophore present, and tDA is the lifetime of the donor fluorophore 
when bound to the protein and transferring energy to the acceptor fluorophore, which 
can be measured as the lifetime of the sensitized emission of the acceptor. Final 
lifetime values for given conditions are obtained by averaging the background-
subtracted lifetime values per day. 
 
smFRET sample preparation 
HEKUX\T cells should be transiently transfected, WV µg per WV cm plate for 
JetPrime reagent. One day post-transfection, cells from two WV-cm dishes are 
harvested and washed with extracellular buffer and labeled for W h at room 
temperature with [VV nM of donor fluorophore Alexa ddd maleimide (ThermoFisher) 
and [VV nM of acceptor fluorophore Alexa ][f maleimide (ThermoFisher) in \ mL 
extracellular buffer. This concentration of fluorophore was determined to be optimal 
for single donor and single acceptor labeling. After washing, the labeled cells are then 
solubilized for W h at [ °C in solubilization buffer (SB) consisting of phosphate-buffered 
saline, W% lauryl maltose neopentyl glycol (Anatrace), U mM cholesteryl hydrogen 
succinate (MP Biomedicals), and ¼ protease inhibitor tablet (Pierce). The 
unsolubilized debris is then spun down for W h at WVV,VVV × g at [°C, and the 
supernatant is used as the smFRET sample. Samples are then diluted W:U in cold SB 
before application. 
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Data collection smFRET 
A confocal microscope is used for data collection. An example confocal system 
that is used for such smFRET experiments is the PicoQuant MicroTime UVV 
Fluorescence Lifetime Microscope. Scan a UV µm x UV µm area of the slide to identify 
molecules for imaging, then record the fluorescence intensity of each molecule until 
the donor and acceptor fluorophores undergo photobleaching. Example traces 
showing anticorrelation between the donor and acceptor are shown in Figure Z.  
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Figure 5. Representative smFRET fluorescence and efficiency traces. 
(a) A representative smFRET trace measured from an agonist binding domain of 
AMPA receptor showing raw trajectories of the donor (blue) and acceptor (red) 
photons as a function of time. (b) The resulting calculated FRET trajectory (green) and 
its denoised counterpart (black). This research was originally published in the Journal 
of Biological Chemistry (157) © the American Society for Biochemistry and Molecular 
Biology. 
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 To ensure that the fluorescence is from the receptor tagged at the site of 
interest, one will need to perform control experiments with no protein, protein with a 
single labeled site, and protein with two labeled sites as shown in Figure [.  
 
 
 
 
 
Figure 6. smFRET slide imaging showing the specificity of labeling strategies.  
smFRET slide imaging showing the specificity of the labeling strategy. Blue pane 
corresponds to donor channel, and brown pane is FRET channel (acceptor frequency 
emission with donor frequency excitation). As seen in (a) there is no labeling when 
protein is not applied to the slide. In (b), the appearance of donor signal is seen when 
protein with single cysteine labeled with fluorophores is applied to the slide. In (c), 
the appearance of FRET is seen when protein with two cysteine labeling sites labeled 
with fluorophores is applied to the slide. This research was originally published in the 
Journal of Biological Chemistry (178) © the American Society for Biochemistry and 
Molecular Biology. 
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Data analysis smFRET 
For data analysis, the donor and acceptor data must be exported as ASCII files. 
Then, corrected FRET efficiencies (EA) can be calculated according to equations [ and 
d: 
 
𝑬𝑨 = (𝟏 + 𝜸
𝑰𝑫
𝑰𝑨
)?𝟏	
Eq.	4	
	
	
𝜸 =
𝜼𝑨𝜱𝑨
𝜼𝑫𝜱𝑫
	
Eq.	5	
 
where ID is the intensity of donor fluorescence, IA is the intensity of acceptor 
fluorescence, γ is a correction factor accounting for the efficiencies of the detectors 
used and for the quantum yield of the fluorophores, η is the efficiency of a given 
detector, and Φ is the quantum yield of a given fluorophore. Once corrected FRET 
efficiencies have been calculated, plot the histograms depicting the distribution of 
various FRET efficiencies and analyze those histograms using any graph software. 
To identify states in the single molecule trajectory, the Hidden Markov 
Modeling (HaMMy) analysis (WfX) or the State Transition and State Identification 
(STaSI) analysis can be used (WYV).  
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Conclusions  
With the incredible advances made in cryo-EM electron detector technology in 
the past WV years, there is no question that the number and quality of cryo-EM based 
molecular structures will continue to grow. These models provide the foundation for 
our understanding of the molecular world; however, limitations in the conclusions 
that can be made concerning the dynamics involved in complex molecular functions 
make it critical that experiments capable of characterizing dynamics be executed in 
parallel. Through the use of MD simulations, molecular models can be integrated with 
structural dynamic experiments and provide a full picture of underlying biophysical 
mechanisms. 
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Chapter 6: FRET Studies of the GluK2 Homomeric Receptor 
 
This chapter is based upon research originally published in Scientific Reports. 
Litwin, D. B., E. Carrillo, S. A. Shaikh, V. Berka, and V. Jayaraman. The structural 
arrangement at intersubunit interfaces in homomeric kainate receptors. Scientific 
Reports. UVWX; X(W):]X]X © Springer Nature Publishing AG. 
 
As discussed in chapter [, several structures are now available for the different 
subtypes of the glutamate receptor (U[, U]-\U, WYW-WY\). These structures show that the 
receptor is organized as a dimer of dimers and ligands bind to the clamshell-like 
agonist-binding domain (Figure ]A). The binding of agonist induces a cleft closure 
conformational change which, when propagated to the transmembrane segments, is 
thought to lead to activation. The activated state also exhibits a coupled dimer 
interface at the agonist-binding domain; decoupling of the dimer interface relieves the 
stress on the transmembrane segments induced by the cleft closure, resulting in 
desensitization (U[, U]-UX, \W, \U, WWf, WYW, WYU).  
However, most of these structures are for the AMPA and NMDA subtype of the 
glutamate receptors. Only three full-length kainate receptor structures are available, 
two in the antagonist-bound form (Ud, UX) and two in the agonist-bound form 
thought to be in the desensitized state (U], UX). These structures fall into two classes, 
the antagonist-bound structure with tight coupling at the interfaces at both the 
amino-terminal domain and agonist-binding domain, and the agonist-bound structure  
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Figure 7. Structural arrangement of the GluK2 receptor and its FRET sites.  
(A) Cryo-EM structure of GluK2 (PDB:5KUF) showing amino-terminal domains 
(ATD), agonist-binding domains (ABD), and transmembrane domains (TMD). (B and 
D) GluK2 ATD and ABD in antagonist-bound form (PDB:5KUH). (C and E) GluK2 
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ATD and ABD in agonist-bound form (PDB:5KUF). Labeling sites are shown as black 
spheres. 
 
 
 
 
 
 
 
 
of the kainate receptor showing large decoupling at the agonist-binding domain with a 
near four-fold symmetry due to extreme decoupling between the dimers (Figure ]A 
and E).  The closely related AMPA receptor structure exists in multiple conformations 
with varying degrees of decoupling at the amino-terminal and agonist-binding domain 
interfaces in the apo (Uf) and agonist-bound forms (U[, U]-UX, \W, \U, WYW, WYU). Thus, 
the question remains as to whether there is an inherent difference in the structure of 
kainate receptor relative to that of the AMPA receptor or is the perceived lack of 
heterogeneity due to the limited structural data currently available.  
Kainate receptors are also unique among the glutamate receptor subtypes in 
exhibiting modulation by Na+ ions. Functional studies have shown that kainate 
receptors require the presence of Na+ and Cl- ions at physiologically relevant 
concentrations to mediate glutamate-gated channel opening and that substitution of 
the sodium ions with other monovalent cations, such as cesium ions, results in the 
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inhibition of the receptor-mediated currents (WWV, WWU-WWd). Structural and 
computational studies on the isolated agonist-binding domain, as well as indirect 
functional studies, indicate that the dimer interface is the binding site for the Na+ (WWV, 
WWU-WWd, WWf, W[U, WY[). Given that the structural insight is based on the isolated agonist-
binding domain, what is still needed to build on this foundation is insight into the 
modulation of the conformational and energy landscapes at this dimer interface by 
ions in the full-length receptor. 
Recently, advances in fluorescence microscopy have made it possible to study 
the conformation-energy landscapes of a variety of molecules. When used in 
combination with previously published structural models, fluorescence resonance 
energy transfer (FRET) allows for the measurement of conformational heterogeneity 
and the energetic quantitation of dynamics within molecules (W\[, Wdd-WdY, W]V, WfV, 
WfY). Herein we use this methodology to study the homomeric full-length kainate 
receptor at sites that are able to monitor proximity within the amino-terminal domain 
and within the agonist-binding domain dimer interfaces that are expected to show the 
conformational variability associated with desensitization and ion modulation. The 
smFRET studies presented herein provide the first look into the structural 
arrangement and dynamics associated with full-length kainate receptor antagonist-
binding, activation, desensitization, and sodium modulation, specifically focusing on 
the interfaces which are thought to be critical in these processes. One limitation of 
this methodology is the millisecond (d ms bins) resolution of the method, thus rapidly 
fluctuating conformations will appear as an average. 
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Results 
 
Functional characterization of FRET constructs and selection of sites 
The GluKUEM construct used previously in cyro-electron microscopy studies 
(U], UX) was modified for FRET experiments to allow for site-specific labeling by 
mutating the non-disulfide bonded cysteines CXW, CWXX, C[\U to serines (GluKU*). Site 
U]] and site [fX were chosen to introduce the donor and acceptor fluorophores based 
on two requirements (Figure ]). First, the sites reflected the large-scale 
conformational changes expected based on the currently available end state structures 
of the antagonist- and agonist-bound forms of the kainate receptor and closely related 
AMPA receptor. Second, the sites are arranged such that the distance being 
investigated (highlighted as darker line) has high FRET efficiency for the FRET donor-
acceptor pair, all other distances are expected to have less than Wd% FRET efficiency 
and if present should occur well separated from the distance of interest (W\[, WfY, WYd, 
WY]). GluKU*-U]]C and GluKU*-[fXC constructs were characterized using 
electrophysiology and show kinetics similar to those of the wild type receptor (Figure 
^). Additionally, these two mutants show a similar decrease in currents upon 
exchange of Cs+ for Na+ in the extracellular buffer (Figure ^).  
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Figure 8. FRET construct characterization for homomeric studies.  
(A) Representative whole-cell recordings for wild-type GluK2, and fluorophore-labeled 
GluK2*266C, GluK2*479C and GluK2*479C-D776K with extracellular 150mM NaCl 
(black traces) or 150mM CsCl (red traces) and in the presence or absence of 10mM 
glutamate. (B) Bar graph showing currents obtained using Cs+ buffer normalized to 
currents obtained using Na+ buffer. 
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Conformational changes at the amino-terminal domain 
In order to compare measurements made with the receptor retained in a lipid 
bilayer with those obtained under detergent solubilized conditions using smFRET, 
LRET measurements were performed on construct GluKU*U]]C. The LRET fluorescent 
decay plots for construct GluKU*U]] under apo conditions show a lifetime of ]WX µs, 
which corresponds to a distance of [U ± V.[f Å. The LRET plots for construct 
GluKU*U]] under glutamate-bound conditions show a lifetime of d]X µs, which 
corresponds to a distance of [W ± V.\X Å, Figure a. These data show that there is no 
significant change in distance at this site between the apo and glutamate-bound 
conditions. 
Denoised smFRET efficiency histograms for the GluKU*-U]]C receptor and 
representative smFRET traces are shown for the apo, antagonist and glutamate-bound 
states in Figure IbA, B and C, respectively. The denoised smFRET efficiency 
histogram was obtained using traces that exhibited single donor and single acceptor 
photobleaching, Figure TbA, thus ensuring that the efficiency corresponds to a single 
donor-acceptor distance. Additional representative smFRET traces are provided in 
Figure II.  The smFRET trajectories were analyzed using the statistical software suites 
STaSI (WYV) (Figure Ib A, B and C) and HAMMY(WfX) Figure TbB. STaSI determines 
the number of states within a data set using a t-test to identify step transitions and a 
minimum description length algorithm to determine the optimal number of states. 
HAMMY creates a model of the step transitions and states that best describe a data set 
using hidden Markov modeling. A comparison of different software by Sigel and 
coworkers showed that STaSI is more accurate in predicting number of states and  
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Figure 9. LRET data for the N-terminal domain construct GluK2*266C.  
Acceptor fluorophore decay plots for GluK2*S266C in the presence of 150 mM NaCl 
under (a) apo conditons and (b) glutamate-bound conditions. Measurements were 
made using terbium chelate (donor) and fluorescein (acceptor). 
 
 
 
 
 
a b 
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Figure 10. smFRET efficiency histograms for construct GluK2*266C.  
Conformational landscape of the dimer-dimer interface at the amino-terminal domain 
at site 266 in full length homomeric GluK2 receptors.  Representative smFRET traces 
and FRET histograms showing fractional occurrence as a function of FRET efficiency 
in (A) the apo state (data from 47 molecules), (B) presence of 1mM UBP310 (data from 
29 molecules) and (C) presence of 1mM glutamate (data from 50 molecules). Traces 
show observed signal in pink, denoised signal in blue, and state transitions in black.  
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Figure 11. Representative FRET efficiency traces for constuct GluK2*266C.  
Representative FRET efficiency traces showing the observed acceptor (green), donor 
(blue) and FRET efficiency (black) in the FRET region for site 266 in the (A) apo state 
(B) glutamate-bound state, and (C) UBP310 bound state. The wavelet based denoised 
data is shown in neon green, cyan and magenta overlaid on the observed data.  
state efficiencies (WYf). However, STaSI uses denoised data while HAMMY is 
performed on observed data, hence we have used both to ensure that denoising is 
accurate.    
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Under apo conditions three FRET efficiency peaks are observed at V.]X, V.Y\ 
and V.XU corresponding to distances of [d Å, \X Å, and \[ Å. The smFRET histogram 
for the antagonist UBP-\WV, on the other hand, shows a single peak at V.fX FRET 
efficiency indicating a single conformation, which corresponds to a distance of [W Å. 
The distances of [d Å in the apo and [W Å in antagonist-bound state are similar to the 
distances of [d Å (PDB:dWEN(\W), dLIB(WY\), \KGU(U[), [U[G(UY)) and [U Å 
(PDB:[UUP(Uf))  at equivalent sites seen in the antagonist and apo state structures of 
closely related AMPA receptors. In the glutamate-bound state two FRET efficiency 
peaks are observed at V.f and V.Y\ that correspond to distances [[ Å and \X Å . These 
distances are similar to the [] Å (PDB:dVHZ(\U), [U[F(UY)) and [V Å 
(PDB:[UUQ(Uf)) seen in the glutamate-bound structures of closely related AMPA 
structures, and [] Å in the agonist-bound structure of kainate receptors 
(PDB:[UQQ(U])). The spread of states observed in the amino-terminal domain in the 
glutamate-bound state of kainate receptors does not show large decoupling as seen in 
Class II and Class III agonist-bound structures of AMPA receptors (Wd).  
 
 
Conformational changes at the agonist-binding domain 
To characterize the conformational and energy landscape at the dimer 
interface of the agonist-binding domain, smFRET experiments were conducted using 
GluKU*-[fXC. smFRET histograms for mutant GluKU*-[fXC in the apo, antagonist, 
and glutamate-bound states in the presence of Na+ are shown in Figure ITA-C. 
Additional representative smFRET traces are provided in Figure IW and corresponding 
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HAMMY fits for the data are show in Figure TbC. The apo state in the presence of Na+ 
has a single peak in histogram showing a single state with a FRET efficiency of V.YX, 
corresponding to a distance of \] Å. The antagonist-bound state also shows a single 
peak but with a more narrow half width indicating a more rigid protein. The FRET 
efficiency is also higher V.Xd corresponding to a distance of \W Å. These data are 
representative of a coupled agonist-binding domain dimer interface and similar to the 
\\ Å seen in the antagonist-bound structure of kainate receptor (PDB:dKUH(UX)). 
 
The smFRET histogram in the presence of glutamate and Na+, on the other 
hand, shows five FRET efficiencies, (Figure ITC), corresponding to distances of dd Å, 
[X Å, [[ Å, \X Å and \\ Å.  These distances are similar the two distances of df Å and dW 
Å between the dimers in current kainate receptor models (PDB:[UQQ(U]), 
dKUF(UX)). However, a large fraction of the receptors show a less decoupled interface 
and these shorter distances have been observed in AMPA receptors, with structures 
showing a distance of  [] Å (PDB:dVHZ(\U), dVOV(\V)) and a distance of \X Å 
(PDB:[UUQ(Uf), [U[F(UY)) at the equivalent sites.  
 
smFRET was next used to characterize the active state structural dynamics of 
the kainate receptor using a Dff]K mutant, which stabilizes the receptor in the open 
state (W[[) (Figure ITD). Additional representative smFRET traces are provided in  
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Figure 12. smFRET efficiency histograms for construct GluK2*479C. 
Conformational landscape at dimer interface at the agonist-binding domain at site 479 
in full length homomeric GluK2 receptors.  Representative smFRET traces and FRET 
histograms showing fractional occurrence as a function of FRET efficiency in presence 
of 150 mM NaCl in the (A) apo state (data from 57 molecules), (B) presence of 1mM 
UBP310 (data from 28 molecules), and C) presence of 1 mM glutamate (data from 66 
molecules), and (D) D776K mutant in the presence of 1mM glutamate (data from 47 
molecules). 
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Figure 13. Representative FRET efficiency traces for constuct GluK2*479C.  
Representative FRET efficiency traces showing the observed acceptor (green), donor 
(blue) and FRET efficiency (black) in the FRET region for site 479 in the (A) apo state 
(B) glutamate-bound state, and (C) UBP310 bound state. The wavelet based denoised 
data is shown in neon green, cyan and magenta overlaid on the observed data.  
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Figure IY.  The smFRET data show that for this open-state stabilized receptor, the 
primary state has a FRET efficiency of V.X\, which corresponds to a distance of \\ Å. 
While both the apo state and the Dff]K glutamate-bound state have primarily one 
main conformation, the striking difference between the two is the half width of these 
states. The half width is narrower in the Dff]K glutamate-bound state relative to that 
in the apo state of the receptor, indicating that the protein is more rigid in the Dff]K 
glutamate-bound state relative to the apo state of the receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
 
 
 
Figure 14. Representative FRET efficiency traces for constuct GluK2*479C-
D776K. 
Representative FRET efficiency traces showing the observed acceptor (green), donor 
(blue) and FRET efficiency (black) in the FRET region for site 479 in the D776K 
background for glutamate bound state in NaCl. The wavelet based denoised data is 
shown in neon green, cyan and magenta overlaid on the observed data. 
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Conformational modulation by ions 
To study the structural effects of ion modulation, smFRET and LRET 
measurements were performed with the kainate receptor in the presence of Cs+ 
(replacing the Na+ ions). Cs+ was chosen as there are extensive electrophysiological 
studies performed under these conditions showing large decreases in currents (WWV, 
WWU-WW[). Thus, direct correlations can be made between the smFRET data and this 
large body of functional studies. Changes are observed between the Na+ and Cs+ 
conditions in the apo state of the receptor.  
When Na+ is replaced with Cs+ a LRET lifetime of d]V µs is found for the apo 
state at site U]], which corresponds to a distance of [W ± V.UU Å, Figure IZ. For the 
glutamate-bound state a lifetime of ]UX µs is found, which corresponds to a distance 
of [U ± V.Wf Å. These data show that similar to Na+ containing conditions, there are no 
significant changes in distance at this site between that apo and glutamate-bound 
conditions. The lifetimes obtained under these conditions correspond to distances of 
[W Å (d]X and d]V µs) and [U Å (]WX and ]UX µs). These distances fit well with the 
distances obtained for this site using smFRET under conditions contain either Na+ or 
Cs+. 
The smFRET denoised histograms show three efficiency peaks in the presence 
of Cs+ (Figure I[A) for site [fX, corresponding to distances of [Y Å, [W Å, and \[ Å, 
respectively. Additional representative smFRET traces are provided in Figure I].  The 
Cs+ conditions are in contrast to the apo state of the receptor in the presence of Na+, 
where the receptor exists primarily in the high FRET more coupled state. The smFRET 
denoised traces for the glutamate-bound state in the presence of Cs+ (Figure I[B)  
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Figure 15. LRET data for the amino-terminal domain construct GluK2*S266C. 
Acceptor fluorophore decay plots for GluK2*S266C in the presence of 150 mM CsCl 
under (a) apo conditons and (b) glutamate-bound conditions. Measurements were 
made using terbium chelate (donor) and fluorescein (acceptor). 
 
 
 
 
 
a b 
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Figure 16. smFRET efficiency histograms for construct GluK2*479C and 
GluK2*479C-D776K in the presence of CsCl. 
Conformational landscape of the dimer interface at the agonist-binding domain at site 
479 in full length homomeric GluK2 receptors.  Representative smFRET traces and 
FRET histograms showing fractional occurrence as a function of FRET efficiency in 
presence of 150 mM CsCl in the (A) apo state (data from 55 molecules), (B) presence of 
1 mM glutamate (data from 52 molecules), and (C) D776K mutant in the presence of 
1mM glutamate (data from 55 molecules). 
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Figure 17. Representative FRET efficiency traces for constuct GluK2*479C in the 
presence of CsCl.  
Representative FRET efficiency traces showing the observed acceptor (green), donor 
(blue) and FRET efficiency (black) in the FRET region for site 479 in the (A) apo and 
(B) glutamate-bound stat in the presence of 150 mM CsCl. The wavelet based denoised 
data is shown in neon green, cyan and magenta overlaid on the observed data. 
Representative FRET efficiency traces showing the FRET regions for site 479. 
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showed FRET efficiencies corresponding to five distances of dW Å, [Y Å, [[ Å, [V Å, 
and \d Å. These distances in Cs+ are similar to the distances of dd Å, [X Å, [[ Å, \X Å 
and \\ Å observed in Na+. However, the occupancies of these states are significantly 
different, with higher occupancy of lower FRET states in Cs+ relative to Na+. These 
results indicate that while the receptor occupies similar conformational states in both 
Cs+ and Na+, the more decoupled states have higher occupancy in the presence of Cs+.  
 
The D]]fK mutant on the other hand did not show any significant shift in the 
states between Na+ (Figure ITD) and Cs+ (Figure I[C), additional representative 
traces shown in Figure I^. Given that the activated state requires coupling between 
the dimers, the larger fraction of the receptors in the low FRET decoupled states in the 
apo state of the receptor in the presence of Cs+ would contribute to the decrease in 
activation observed in the presence of Cs+. 
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Figure 18. Representative FRET efficiency traces for constuct GluK2*479C-
D776K in the presence of CsCl. 
Representative FRET efficiency traces showing the observed acceptor (green), donor 
(blue) and FRET efficiency (black) in the FRET region for site 479 in the D776K 
background for glutamate bound state in CsCl. The wavelet based denoised data is 
shown in neon green, cyan and magenta overlaid on the observed data.  
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State transitions and energy landscape  
In addition to providing the state occupancy, the smFRET trajectories allow for 
the direct observation of transitions between different states, specifically in the 
desensitized and Cs+ conditions, as exemplified by the representative traces in Figures 
IT and I[. Based on these data, we have obtained transition maps showing the relative 
number of transitions between states (Figure Ia). The data show that within the 
agonist-binding domain, transitions primarily occur between states of nearest FRET 
efficiency, whereas transitions between non-adjacent states are less common. The 
probability of observing these non-adjacent state transitions is higher in the presence 
of Cs+ under desensitizing conditions, which suggests a lower energy barrier for the 
transitions. These data are consistent with the energy maps and show that in the 
presence of both glutamate and Na+, the lowest energy barrier of transition is between 
the high-FRET states with efficiencies of V.X\ and V.YU. However, in the presence of 
both glutamate and Cs+, the activation energy barriers are similar across all states. 
These data indicate that with Na+ present the receptor is more stable in the coupled 
state and requires more energy to transition into states with increasing distance, and 
that in the presence of Cs+ the receptor is able to move across states with relatively 
low energy barriers. 
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Figure 19. Transition maps and free energy diagrams based on the smFRET data 
at site 479. 
Transition maps showing transitions from a given FRET efficiency to a given FRET 
efficiency (i) and free energy associated with the transitions (ii) in (A) 150 mM CsCl, 
(B) 150 mM NaCl and 1mM glutamate, and (C) 150 mM CsCl and 1mM glutamate. 
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Figure 20. Representative trace and Gaussian fit histograms for homomeric 
studies. 
(A) Representative traces showing single photobleaching step for donor and acceptor 
and anticorrelation showing that the donor and acceptor are from FRET pairs. 
Observed histograms with data being fit using Gaussians based on HAMMY analysis 
for (B) GluK2*S266C (i) in apo conditions, (ii) in the presence of 1mM glutamate and 
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(iii) in the presence of 1 mM UBP310. (C) GluK2*479C with 160 mM NaCl and in apo 
conditions (i), (ii) in the presence of 1mM glutamate and (iii) in 150 mM NaCl with 
1mM UBP310. (D)  GluK2*479C with 150 mM CsCl and in the absence (i) and presence 
(ii) of 1mM glutamate.(E) GluK2*479C-D776K with (i) 150 mM NaCl and 1mM 
glutamate and (ii) 150 mM CsCl and 1mM glutamate. 
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Discussion 
There are several X-ray crystallographic structures of isolated domains for all 
subtypes of the ionotropic glutamate receptor. Studies of the full-length receptor, 
however, have been primarily focused on the AMPA and NMDA subtypes (U[, U], Uf, 
UX, \U, WYW, WYU), with only an antagonist- and agonist-bound structure of the full-
length kainate receptor. The structures (U[, U]-UX, \W, \U, WYW, WYU), spectroscopic 
investigations (Wdf, WdY, W]V, WfV, WfY, WYY, WYX), and molecular dynamic simulations of 
AMPA and NMDA receptors (WXV-WXU) show that the protein occupies multiple 
conformations under any given condition and such diversity in conformation is 
consistent with the diversity of states seen in single channel recordings of these 
receptors. More importantly, these studies suggest that the receptor function is 
dictated to a large extent by conformational selection. However, this structural 
heterogeneity has not been shown for the kainate receptors. Herein we have used a 
combination of LRET and smFRET measurements to resolve the conformational 
landscape of the full-length kainate receptor under physiologically-relevant conditions 
in the antagonist-bound, apo, active, and desensitized states and additionally have 
identified the changes in kainate receptor dynamics induced by Na+ modulation. 
  
The resting state 
Detailed structural models of the apo state of the kainate receptor have been 
particularly elusive; the only structural information with respect to the resting state 
has been derived from the structure of the antagonist-bound form of the receptor. The 
smFRET data show that under apo conditions in the presence of Na+, the agonist-
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binding domain exists primarily in one conformation, with a distance consistent with 
a coupled dimer interface, but structural heterogeneity is observed at the amino-
terminal domain with a small distance range. This is similar to what is seen in the 
AMPA receptors (\W). Additionally, the distances corresponding to the FRET 
efficiencies obtained match well between LRET and smFRET measurements. In the 
presence of Cs+ ions, on the other hand, the dimer interface exhibits both coupled and 
decoupled conformations. Because the active state requires the agonist-binding 
domain interface to be coupled, this decoupled dimer interface would require more 
energy to be converted to the active state and can account for the lower receptor 
activation observed in the presence of Cs+. 
 
The antagonist-bound state 
The smFRET histograms for the antagonist-bound state at both the amino-
terminal domain and agonist-binding domain show single states that are similar to the 
most probable state seen in the resting apo state. However, the antagonist-bound 
state is clearly more rigid at these interfaces, exhibiting a smaller half width even in 
this single state. 
  
The active state 
The smFRET data on the Dff]K mutant, which stabilizes the receptor in the 
open, activated state, show that the agonist-binding domain dimers remain primarily 
coupled in the active state and that substituting Cs+ for Na+ has no effect. These data 
are consistent with the structure and molecular dynamics simulations of the Dff]K 
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mutant that show the introduced lysine can occupy the Na+ binding site  (WWf), 
eliminating the requirement for Na+ to activate. Furthermore, these data are 
consistent with the electrophysiological measurements which show a similar extent of 
activation under both Na+ and Cs+ conditions (WWf). The smFRET data showing a tightly 
coupled active state in the D]]fK mutant with a much smaller full width at half 
maximum relative to the apo state, indicates that this structural rigidity at the 
interface allows for the channel to be constitutively active with high probability of 
opening as seen in single channel recordings (WWf).  
 
The desensitized state 
Current structures of kainate and AMPA receptors under desensitizing 
conditions show significant differences between the two closely-related subtypes. At 
the amino-terminal domain, the kainate receptor showed minimal decoupling, while 
the AMPA receptor showed varying degrees of decoupling. At the agonist-binding 
domain the kainate receptors showed complete decoupling with the receptor 
transitioning into a near four fold symmetry, while the AMPA receptor showed 
smaller decoupling (U[, Uf, UY, \U, WYU). However, cysteine crosslinking studies by 
Soblovesky and coworkers question the large decoupling seen in the AMPA receptors 
(\\), as desensitization is observed even in the cross-linked non-decoupled receptor.  
 
The smFRET measurements under desensitizing conditions showed 
heterogeneity at the dimer-dimer interface at the amino-terminal domain and 
minimal decoupling. This would be similar to the non-decoupled states seen with 
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crosslinking (\\). Additionally, the smFRET data show that the large decoupled 
agonist-binding domain structure seen in the cryo-EM structure accounts for a small 
fraction of the receptors in the desensitized state. However, a large fraction of the 
receptors show no or slight decoupling similar to what has been observed in the 
AMPA receptors. Based on the smFRET measurements it can be concluded that 
kainate and AMPA receptors exhibit largely similar trends in terms of structural 
heterogeneity in the desensitized state with much smaller differences than was 
previously thought.  
 
SmFRET measurements characterizing the proximity of the agonist-binding 
domain dimers in the presence of Cs+ show that the more decoupled states are 
favored, and the energy barrier is lowered for transitions to more decoupled states. 
This decrease in energy barrier is consistent with MD simulations that showed a 
decrease in the work required to decouple the dimer interface in the absence of Na+ 
ions (WWf, W[U). The fact that the conformational states of the agonist-binding domain 
are the same in both Na+ and Cs+ conditions suggest a conformational selection 
mechanism.  The occupancy of similar states is consistent with the fact that the X-ray 
structures of the isolated agonist binding domain are similar under both Na+ and Cs+ 
conditions. The smFRET data adds to this prior knowledge by showing that the 
occupancy of these states are shifted.  
Importantly, similar distances are found between sites U]] when measured 
using both LRET and smFRET. The comparison of these data indicate that the 
receptor is in a similar conformational arrangement in either lipid bilayer or detergent 
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solubilized and that a direct comparison can be made between the two techniques. 
Unfortunately, LRET measurements were limited to the ATD due to functional 
limitations of the receptor. 
 
Conclusions 
Using a combination of LRET and smFRET measurements we have 
characterized the conformation and energy landscapes of the kainate receptor in the 
apo, antagonist-bound, active, desensitized, and Na+-modulated states. These data 
suggest a similar conformational heterogeneity as seen in the AMPA receptors. The 
desensitized and resting states of the receptor are energetically altered in the presence 
of Cs+, which drives the protein into a decoupled dimer state which in turn leads to 
lower activation. 
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Chapter 7: FRET Studies of the GluK2/GluK5 Heteromeric Receptor 
 
This chapter is based upon research originally published in Biochimica et 
Biophysica Acta- Biomembranes. Litwin, D. B., N. Paudyal, E. Carrillo, V. Berka, and V. 
Jayaraman. The structural arrangement and dynamics of the heteromeric 
GluKU/GluKd kainate receptor as determined by smFRET. Biochimica et Biophysica 
Acta- Biomembranes. UVWX; DOI: WV.WVW]/j.bbamem.UVWX.Vd.VU\ © Elsevier B.V. 
 
As discussed in chapter [, the majority of ionotropic glutamate receptor 
models available are of the AMPA and NMDA subtype with only three available for 
full-length homomeric GluKU kainate receptors, one in the antagonist-bound form 
(Ud, UX) and two in the agonist-bound form exhibiting desensitized state (U], UX). The 
structural data available for the homomeric kainate receptor has laid a foundation for 
our understanding of the structural characteristics that give rise to the unique 
function of kainate receptors.  
The heteromeric GluKU/GluKd kainate receptor is known to be the most 
abundant kainate receptor expressed in the brain (WX\). Therefore, identifying the 
structural features that are unique to the GluKU/GluKd heteromer is crucial to design 
therapeutically potential kainate receptor specific compounds. Yet, the only structural 
models currently available for the heteromeric kainate receptor are of the isolated 
amino-terminal domains (WUd). MD simulations on the homology model of isolated 
agonist-binding domain dimer show that the heteromeric receptor has more 
decoupled dimer interface relative to the homomeric receptors (WY[). Functionally the 
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GluKU/GluKd heteromer has shown higher glutamate sensitivity (Yd, WX[-WX]) and a 
faster rate of desensitization (tdes GluKT/KZ = ~\ ms) compared to the homomeric 
receptor (tdes GluKT = d.Y ms) in the presence of sodium ions (WY[). These differences in 
function leave no question that there are valuable structural characteristics of 
heteromeric kainate receptors left to be resolved. The only advances in our 
understanding of the structure of the GluKU/GluKd heteromer show that they localize 
to the plasma membrane with a subunit stoichiometry of U:U and that the GluKU 
amino-terminal domains likely mediate the amino-terminal domain dimer-dimer 
interface (WU[, WUd).  
 
FRET acts as a molecular ruler providing distances between the donor and 
acceptor fluorophores attached to specific sites of a molecule, and when used at the 
single molecule level allows for investigating the conformational landscape and 
energetics of functionally-significant dynamics within molecules (W\[, Wdd-WdY, W]V, 
WfV, WfY). For the single molecule FRET (smFRET) measurements, membrane 
preparations of cells expressing the protein  used with minimal purification, thus 
providing insight into the proteins in a near native conformation (W\[, Wdd-WdY, W]V, 
WfV, WfY). Here, we have used smFRET to address the specific arrangement of the 
receptor, and to understand the conformational landscape of the heteromeric 
receptor, specifically the conformational landscape across the dimer-dimer interface at 
the amino-terminal domain, the dimer interface at the agonist-binding domain and at 
the transmembrane segments. These sites were chosen as they are known to play 
important roles in activation and desensitization in the homomeric kainate receptor 
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and/or the closely related AMPA receptor (\\, W[\, WXf-WXX). Additionally, the sites at 
the amino-terminal domain and agonist-binding domain are equivalent to those that 
we used to study the homomeric receptors (UVV), thus a direct comparison of 
differences between the conformational landscape of the heteromeric and homomeric 
receptors can be made and correlated to differences in function. 
 
Results and discussion 
For smFRET measurements we modified the GluKU and GluKd receptors to 
remove accessible cysteines as shown in Figure TI (modified constructs are referred to 
as GluKU* and GluKd*). Additionally, we have introduced a twin strep tag on the 
background of GluKd constructs. Since, GluKd subunits do not express as homomeric 
receptors (WU[, WdW, UVW-UV\), performing the in situ pull down using streptavidin on 
membrane preparations of HEK-UX\ cells co-expressing GluKU and GluKd subunits 
allows for the specific attachment of GluKU/GluKd receptors and excludes the 
attachment of GluKU homomeric receptors.  
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Figure 21. Structural arrangement of the GluK2/GluK5 heteromeric receptor. 
Extracellular amino-terminal domain (ATD) and agonist-binding domain (ABD) 
represented as bilobed structures in domain swapping configuration. Accessible 
cysteines modified to form cysless constructs for GluK5 and GluK2 subunits are shown 
as red spheres. Transmembrane domain (TMD) consisting of four helices M1, M2, M3 
and M4, are represented as cylindrical structure inside the membrane. A twin-strep 
tag is attached to the C-terminus of GluK5 subunit shown in green. 
 
 
 
 
80 
 
Arrangement of GluK2 and GluK5 subunit with the kainate receptor.  
Given that the kainate receptor subunits are arranged as dimer of dimers, the 
GluKU and GluKd subunits can be assembled in three possible configurations (Figure 
TT). To determine the configuration(s) that the receptor occupies using smFRET, we 
measured distances between sites U]] and U]] in the two GluKU subunits, and 
equivalent sites UfU and UfU in the two GluKd subunits, within the GluKU/GluKd 
heteromeric receptors. These sites were chosen based on homology models of the 
GluKU/GluKd receptors generated which show that the distances between these sites 
can be used to clearly differentiate between the possible configurations (Figure TW A-
C). The functionality of GluKU*-U]]/GluKd* and of GluKU*/GluKd*-UfU subunits 
labeled with Alexa ddd and Alexa ][f fluorophores were established using whole cell 
current recordings (Figure TY). 
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Figure 22. Representation of the possible arrangments of the heteromeric 
amino-terminal domains. 
Possible configurations for amino-terminal domains of GluK2 and GluK5 subunits in 
GluK2/GluK5 heterotetramer forming dimer of dimers. 
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Figure 23. Homology models for heteromeric sites GluK2*-266 and GluK5*-272 
with corresponding efficiency histograms. 
(A) Full-length structure of the apo state GluK2/GluK5 heteromer (homology model 
made from PDB 3KG2) with the GluK2 subunits shown in blue and the GluK5 subunits 
shown in green. Alpha carbon sites at GluK2*-266 are shown as red spheres. (B-C) Top 
down view of alpha carbon sites at GluK5*-272 and alpha carbon sites at GluK2*-266 
with their corresponding distances. (D-E) smFRET data for GluK2*-266 sites; with two 
representative smFRET efficiency traces for individual molecules shown in panel D 
and cumulative smFRET efficiency traces with observed data (grey) overlaid on 
denoised data (red) are shown in panel E. Gaussian fits shown in black, blue and 
green, represents the smFRET efficiency states. 
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Figure 24. Heteromeric FRET construct characterization. 
Representative whole-cell recording for GluK2*-523/GluK5*, GluK2*/GluK5*-272, 
GluK2*-266/GluK5*, GluK2*-479/GluK5*-471 and GluK2*/GluK5*-515. 
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smFRET traces for constructs GluKU*-U]]/GluKd* exhibiting a single donor 
and single acceptor photobleaching step with anticorrelation upon acceptor bleaching 
were used for generating the smFRET efficiency traces for individual molecules 
(representative trace shown in Figure TWD). The fractional occurrence in the smFRET 
efficiency traces were then used to generate the smFRET efficiency histogram. The 
cumulative histogram from smFRET efficiency traces from UY molecules, for GluKU*-
U]]/GluKd* is shown in (Figure TWE). The donor and acceptor traces were denoised 
using wavelet based denoising and the denoised FRET histograms generated from 
these are shown overlaid on the observed histogram (Figure TWE). The smFRET 
histogram shows primarily two states with a FRET efficiency of V.fU and V.Y\, 
corresponding to distances of [U Å and \X Å. These distances are close to the alpha 
carbon distance between the U]] and U]] residues (values are shown in Table I) as 
predicated when placing the GluKU subunits proximal to each other (Figure TTA). 
Additionally, given that this distance is significantly shorter than the distance of ]f Å 
expected in the configuration placing two GluKU subunits within the dimer as seen in 
GluKU homomer (PDB dKUH), it can be concluded that the configuration with GluKU 
(Figure TTB) within the peripheral position the dimer does not exist in the heteromer. 
smFRET experiments for the GluKU*/GluKd*-UfU receptors on the other hand 
showed no molecules with significant smFRET efficiency traces. W[Y molecules probed 
exhibited one or multiple donor steps or one or multiple acceptor steps, but no 
molecules showed FRET between the donor and the acceptor. Based on this 
observation it can be concluded that no significant fraction of the GluKU/GluKd 
heteromeric receptors exist in the configuration placing the GluKd subunits proximal  
 
85 
 
 
 
Sites 
 
Apo state 
 
Desensitized state 
Alpha carbon distance in 
Å for homology models  
FRET 
Eff.* 
 
Gaussian fit 
FRET 
Eff.* 
 
Gaussian fit 
 
5KUF 
 
3KG2 
 
5KUH 
GluK2*-266 - 
GluK2*-266 
 
0.72 
 
0.83 
0.72 (+/- 0.03 
 
0.84 (+/- 0.004 
 
 
- 
 
 
 
- 
 
 
47 
 
 
44 
 
 
- 
 
 
GluK2*-479 - 
GluK5*-471 
 
0.8 
 
0.9 
0.80 (+/- 0.003 
 
0.90 (+/- 0.001 
0.56 
0.69 
0.83 
0.84 
 
0.56 (+/- 0.01) 
0.68 (+/- 0.003) 
0.83 (+/- 0.001) 
0.93 (+/- 0.002) 
 
 
37 
 
 
 
 
39 
 
 
 
 
57 
GluK2*-523 - 
GluK2*-523 
 
0.83 
 
0.96 
 
 
0.83 (+/- 0.005) 
 
0.96 (+/- 0.002) 
0.85 
 
0.94 
0.83 (+/- 0.008) 
 
0.94 (+/- 0.002) 
 
 
- 
 
 
34 
 
 
 
 
38 
GluK5*-515 - 
GluK5*-515 
 
0.81 
 
0.94 
0.81 (+/- 0.003) 
 
0.94 (+/- 0.002) 
0.84 
 
0.93 
0.85 (+/- 0.01) 
 
0.95 (+/- 0.003) 
 
 
 
- 
 
34 
 
38 
Table 1. Summary of smFRET efficiencies and distances calculated 
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to each other (Figure TTC) and within a dimer (Figure TTB). Therefore, the 
heteromeric receptor exists primarily in the configuration shown in Figure TTA.  and 
is consistent with the X-ray structure of the isolated amino-terminal domain of the 
GluKU-GluKd heterotetramer (WUd).  
 
Comparison of the conformational landscape of heteromeric to homomeric receptors at 
dimer-dimer interface at the amino-terminal domain. 
 The smFRET data of GluKU*-U]]/GluKd* show two states with FRET 
efficiencies of V.fU and V.Y\, while the smFRET data of homomeric GluKU receptors at 
this site showed three states of FRET efficiencies V.]X, V.Y\ and V.XU (UVV). The most 
probable state of V.Y\ is identical in both suggesting that the two receptors have a 
similar conformational arrangement of the dimer-dimer interface at the amino-
terminal domain for the main conformational state. The similarity in primary 
conformation and lack of large-scale differences at the amino-terminal domain 
between the homomeric and heteromeric receptors would be consistent with the 
previous biochemical studies suggesting that the amino-terminal domain plays a 
major role in assembly (WUd, UV[).   
 
Conformational landscape of the agonist-binding domain. 
To study the conformational dynamics at the dimer interface in the agonist-
binding domain, we introduced cysteines at site [fX on GluKU* and [fW on GluKd* 
(Figure TZA-B). These sites are ideal as the distance between these residues are 
distinct within the dimer, relative to that across the dimers (Figure TZB). smFRET 
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traces showing a single donor and single acceptor photobleaching step with 
anticorrelation between the two were used to generate the FRET efficiency traces, and 
U]-UY molecules were combined to generate the cumulative smFRET efficiency 
histograms. The smFRET histograms in the apo state show two states with efficiencies 
of V.Y and V.X (Figure TZD), corresponding to distances of [V Å and \d Å. These 
distances are close to the alpha carbon distance between residues GluKU*-[fX and 
GluKd*-[fW (values are shown in Table W) based on homology models when placing the 
subunits as in configuration Figure TTA, further confirming that this is the primary 
configuration for the heteromeric receptor. The smFRET histograms for the 
glutamate-bound state, on the other hand, shows four states with FRET efficiencies of 
V.d], V.]X, V.Y\ and V.X[ (Figure TZD). The lower FRET efficiency state V.d] with a 
distance of [X Å corresponds well with the distance of dW Å observed in the 
desensitized state structure of GluKU homomeric receptor (PDB dKUH) showing a 
pseudo four-fold symmetry, suggesting that a fraction of the protein exists in the 
conformation similar to this structure under desensitizing conditions. However, the 
conformations with less decoupling at the dimer interface of the agonist-binding 
domain also exist suggesting that complete decoupling as seen in the pseudo four-fold 
symmetry is not essential for desensitization. 
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Figure 25. Homology model for heteromeric sites GluK2*-479 and GluK5*-471 
with corresponding efficiency histograms. 
(A) Full-length structure of the apo state GluK2/Gluk5 heteromer (homology model 
made from PDB 3KG2) with alpha carbon sites at GluK2*-479 (magenta spheres) and 
GluK5*-471 (red spheres). (B) Top down view of alpha carbon sites at GluK2*-479 
(magenta spheres) and at GluK5*-471 (red spheres) with their corresponding measured 
distances at apo state (left panel) (homology model made from PDB 5KUH) and 
desensitized state (right panel) (homology model made from PDB 5KUF) of 
GluK2/GluK5 heteromer. (C-D) smFRET data for GluK2*-479 and GluK5*-471 sites at 
the apo state (left panel) and the desensitized state (right panel). (C) Two 
representative smFRET efficiency traces for individual molecules. (D) Cumulative 
smFRET efficiency traces with observed data (grey) overlaid on denoised data (red). 
Gaussian fits shown in black, blue and green, represents the smFRET efficiency states. 
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Comparison of the conformational landscape of heteromeric to homomeric receptors at 
the agonist-binding domain dimer interface.  
The smFRET histograms of the heteromeric receptor in the apo state shows the 
additional lower FRET state of V.Y, which is not observed in the smFRET histogram of 
the homomeric GluKU receptor in the apo state. The apo state of the homomeric 
GluKU receptor exists in a single conformation with a FRET efficiency of V.YX (UVV). 
The existence of a more decoupled second conformation in the heteromeric receptor 
is consistent with prior MD simulations with the isolated agonist-binding domain 
where a shift of about W Å towards a more decoupled state was observed (WY[). The 
smaller shift in the MD simulations versus that seen in the smFRET could be due to 
the fact that the distances were measured closer to the dimer interface in the MD 
simulations and not at the same site being studied in the smFRET measurements. 
Additionally, the simulations were on the isolated domain and it is possible that the 
changes are larger in the full-length receptor. 
A favoring of the more decoupled state is also observed in the smFRET data for 
the glutamate-bound homomeric (desensitized) state (UVV). While, the FRET 
efficiencies of V.d], V.]X, V.Y\ and V.X[ in the glutamate-bound state for the 
heteromeric receptors are similar to the FRET efficiencies of V.d[, V.]X, V.YU and V.X\ 
seen in the homomeric GluKU receptors, the fractional occupancy is higher for the 
more decoupled state in the heteromeric receptors relative to the homomeric 
receptors. This shift towards the more decoupled state would be consistent with the 
faster desensitization rates observed in the heteromeric receptors relative to the 
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homomeric receptors (tdes GluKT/KZ = ~\ ms, tdes GluKT = d.Y ms) in the presence of 
sodium ions (WY[). 
 
Conformational landscape at the transmembrane segments. 
In order to study the conformational dynamics at the transmembrane 
segments we introduced cysteines at site dU\ on GluKU* and dWd on GluKd* (Figure 
T[, T]). These sites are positioned at the top of the first transmembrane segment, 
which makes them ideal to measure the distance across the pore axis at 
complementary sites. smFRET traces showing a single donor and single acceptor 
photobleaching step with anticorrelation between the two were used to generate the 
FRET efficiency traces, and Uf-\W molecules were combined to generate the cumulative 
smFRET efficiency histograms. The smFRET histograms for GluKU*-dU\ in the apo 
state show two states with efficiencies of V.Y\ and V.X] (Figure T[D) and correspond 
to distances of \X and \V Å. These distances are close to the alpha carbon distance of 
residue dU\ - dU\ in the two GluKU subunits obtained from the apo state homology 
model with the channel being in a closed state (Figure T[ A-B, Table I). The higher 
FRET efficiency peak centered at V.X] that corresponds to a distance of \V Å possibly 
represents a tighter packing at the transmembrane segment. The smFRET histograms 
for GluKU*-dU\ in the glutamate-bound state show two peaks with efficiencies of V.Yd 
and V.X[ (Figure T[D), corresponding to distances of \Y and \U Å. These efficiencies 
are similar to what is found under apo conditions at this site; however, there is a 
significant shift in occupancy toward the high FRET state, suggesting the more tightly 
packed transmembrane conformation is favored in the desensitized state.  
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Figure 26. Homology model for heteromeric sites GluK2*523 and GluK5* with 
corresponding efficiency histograms. 
(A) Full-length structure of the apo state GluK2/Gluk5 heteromer (homology model 
made from PDB 3KG2) with alpha carbon sites at GluK2*-523 (red spheres). (B) Top 
down view of the apo state (left panel) (homology model made from PDB 3KG2) and 
the desensitized state (right panel) (homology model made from PDB 5KUF) of 
GluK2/GluK5 heteromer displaying alpha carbon sites at GluK2*-523 (red spheres) 
with their corresponding measured distances. (C-D) smFRET data for GluK5*-523 sites 
at the apo condition (left panel) and the desensitized state (right panel). (C) Two 
representative smFRET efficiency traces for individual molecules. (D) Cumulative 
smFRET efficiency traces with observed data (grey) overlaid on denoised data (red). 
Gaussian fits shown in black, blue and green, represents the smFRET efficiency states. 
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The smFRET histograms for GluKd*-dWd in the apo state show two states with 
efficiencies of V.YW and V.X[ (Figure T]D) and correspond to distances of [V and \U, 
and in the glutamate-bound state show two peaks with efficiencies of V.Y[ and V.X\ 
(Figure T]D), corresponding to distances of \X Å and \\ Å. The smFRET data from 
site GluKd*-dWd are similar to site GluKU*-dU\ in the glutamate-bound state showing 
that at this site the protein exhibits a four-fold symmetry in both the apo and 
glutamate-bound state. 
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Figure 27. Homology model for heteromeric sites GluK2* and GluK5*-515 with 
corresponding efficiency histograms. 
(A) Full-length structure of apo state GluK2/Gluk5 heteromer (homology model made 
from PDB 3KG2) with alpha carbon sites at GluK5*-515 (red spheres). (B) Top down 
view of the apo state (left panel) (homology model made from PDB 3KG2) and the 
desensitized state (right panel) (homology model made from PDB 5KUF) of 
GluK2/GluK5 heteromer displaying alpha carbon sites at GluK5*-515 (red spheres) with 
their corresponding measured distances. (C-D) smFRET data for GluK5*-515 sites at 
apo condition (left panel) and desensitized state (right panel). (C) Two representative 
smFRET efficiency traces for individual molecules. (D) Cumulative smFRET efficiency 
traces with observed data (grey) overlaid on denoised data (red). Gaussian fits shown 
in black, blue and green, represents the smFRET efficiency states. 
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Conclusions 
There are a plethora of X-ray crystallography and cryo-EM structural models 
available for the AMPA and NMDA classes of iGluR including both isolated amino-
terminal and agonist-binding domains, and also the full-length receptors. However, 
only three structural models have been produced for the full-length homomeric GluKU 
receptor type. Currently, there are no structures of the full-length GluKU/GluKd 
heteromeric receptor. Using smFRET investigations, we show that GluKU/GluKd 
heteromeric receptor assemble in one configuration with the GluKU sites occupying 
proximal positions across the dimer-dimer interface at the amino-terminal domains of 
the receptor. Additionally, we show that the spread of conformational states is not 
significantly different between the homomeric and heteromeric receptors at the 
dimer-dimer interface at the amino-terminal domain suggesting that the primary role 
of this domain is in assembly. The agonist-binding domain, on the other hand, shows 
more decoupling and a higher occupancy of the decoupled state at the dimer interface 
in both the apo and glutamate-bound states of the heteromeric receptors relative to 
what is observed in the homomeric receptors. Given the prior studies that have shown 
the decoupling of the dimer interface at the agonist-binding domain as being the 
primary conformational change driving desensitization, the increase in decoupling at 
this interface in the agonist binding domain of the heteromeric receptor ties back to 
the functional studies that show a faster desensitization rate in the heteromeric 
receptor relative to the homomeric receptors. The smFRET studies also show that the 
GluKU/GluKd heteromeric receptors loses its two-fold symmetry and exhibits four- 
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fold symmetry at the start of the first transmembrane segment in both the apo and the 
glutamate-bound forms of the receptors. 
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Chapter 8: The Effects of Neto Modulation on Kainate Receptor Structure 
 
Parts of this chapter are based upon research originally published in 
Biophysical Journal. Prakash, P., D.B. Litwin, H. Liang, J. Hancock, V. Jayaraman and 
A. Gorfe. Dynamics of membrane-bound GWUV-KRAS from simulations and single-
molecule FRET in native nanodiscs. Biophysical Journal. UVWX; WW](U): WfX-WY\ © 
Biophysical Society. 
 
As discussed in chapter \, there are significant changes in the kinetics of KAR 
gating when co-expressed with Neto proteins. There is currently no structural data for 
Neto proteins or KARs as affected by Neto proteins. In order to characterize the 
structural effects of Neto modulation on KARs, LRET and cryo-EM experiments were 
conducted on the homomeric GluKU KAR co-expressed with NetoU. 
The architecture of the KAR positions the amino-terminal on the extracellular 
side of the plasma membrane. Neto proteins are also in this arrangement. Given that 
the two proteins are positioned with intercellular C-termini, it is not possible to create 
a tandem construct for structural studies, as has been done with AMPARs and 
stargazin. This creates difficulty in studying the structure of this complex using 
smFRET and cryo-EM.  
LRET, however, provides an excellent platform for circumventing this issue. 
LRET experiments allow for measurements to be made on non-purified samples, such 
as HEK cells expressing the protein of interest as seen in previous chapters. Therefore, 
the amino-terminal domain constructs which retained function were ideal candidates 
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to begin characterizing the structural influences of Neto proteins and as previously 
discussed, there is evidence that Neto proteins interact with the ATDs of the KAR. 
Given that loss of function was observed for KAR mutants designed for measurements 
in the ABD layer, purification strategies capable of maintaining the KAR-Neto 
interactions were further investigated. 
While detergents like digitonin have been used in structural studies of protein 
complexes, there have been difficulties in obtaining quality samples of KARs purified 
using these methods. Therefore, solubilizing agents capable of forming nanodiscs 
including lipid bilayer were considered for testing. Currently, the only technologies 
shown to be capable of maintaining protein complexes in nanodiscs are membrane 
scaffold protein (MSP) and styrene maleic acid copolymers (SMA). Since SMA does 
not require pre-solubilization in detergents, a purification strategy utilizing SMA was 
optimized for use in cryo-EM studies of the KAR-NetoU complex. Preliminary LRET 
and cryo-EM imaging experiments will be discussed in this chapter. 
 
Amino-terminal domain LRET studies of the KAR-Neto complex 
 As discussed in chapter \, several studies have highlighted the role of the ATD 
in the trafficking of Neto proteins. While the specific mechanisms involved in the 
KAR-Neto interaction are not currently known, these data hint that there could be 
important interactions between the KAR ATD and Neto proteins. For this reason, 
LRET experiments were conducted using construct GluKU*UUC and GluKU*U]]C, and 
GluKU*UUC and GluKU*U]]C co-expressed with NetoU. These constructs are design to 
monitor the distance within ATD dimer pairs and between ATD dimer pairs 
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respectively. As previously mentioned, LRET experiments were limited to the ATD due 
to loss of function with ABD constructs. 
In order to characterize the effect of Neto modulation on the KAR ABD dimers, 
LRET measurements were made on construct GluKU*UUC. LRET decay plots for 
construct GluKU*UUC co-expressed with NetoU are shown in Figure T^. Under apo 
conditions and without NetoU present, the LRET lifetime obtained is f\W µs. This 
corresponds to a distance of [[ ± V.Ud Å. Under glutamate-bound conditions without 
NetoU, the lifetime obtained was fWY µs, which corresponds to a distance of [[ ± V.]W 
Å. Under apo conditions and with NetoU co-expressed, the lifetime obtained was dYV 
µs which corresponds to a distance of [W ± W.W Å. Under glutamate-bound conditions 
with NetoU co-expressed, the lifetime was df\ µs, which corresponds to a distance of 
[W ± V.YY Å. These data show that there is slight decrease in distance at site UUC when 
GluKU is expressed with NetoU. 
 In order to characterize the effects of Neto modulation on the distance 
between ATD dimer pairs, LRET measurements were conducted on construct 
GluKU*U]]C shown in Figure ]. The fluorescent decay plots for construct 
GluKU*U]]C are shown in Figure Ta. Under apo conditions without NetoU co-
expressed the lifetime was ]WX µs which corresponds to a distance of [U ± V.[f Å. 
Under glutamate-bound conditions without NetoU co-expression the lifetime was d]X 
µs which corresponds to a distance of [W ± V.\X Å. Under apo conditions with NetoU 
co-expressed the lifetime was WVV\ µs, which corresponds to a distance of dV ± V.XW Å. 
Under glutamate-bound conditions NetoU co-expression the lifetime was XXV µs, 
which corresponds to a distance of dV ± W.\ Å. These data indicate that when GluKU is 
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co-transfected with NetoU, the ATD dimer pairs are separated by a greater distance 
than when expressed alone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. LRET data for amino-terminal domain construct GluK2*22C. 
(a) Acceptor fluorophore decay plots under apo conditons for GluK2*22C (black) and 
in the presence of Neto2 (blue). (b) Acceptor fluorophore decay plots under 
glutamate-bound conditions for GluK2*22C (black) and in the presence of Neto2 
(blue). Measurements were made using terbium chelate (donor) and fluorescein 
(acceptor). 
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Figure 29. LRET data for the amino-terminal domain construct GluK2*266C. 
(a) Acceptor fluorophore decay plots under apo conditons for GluK2*266C (black) and 
in the presence of Neto2 (blue). (b) Acceptor fluorophore decay plots under 
glutamate-bound conditions for GluK2*266C (black) and in the presence of Neto2 
(blue). Measurements were made using terbium chelate (donor) and fluorescein 
(acceptor). 
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Agonist-binding domain LRET studies of the KAR-Neto complex 
To measure the effect of Neto co-expression on the ABD dimer proximity, 
construct GluKU*[dY was characterized using LRET, shown in Figure Wb. Fluorescent 
decay plots are presented in Figure WI. Under all conditions, florescent decay plots 
which fit to double exponential decay were produced. Under apo conditions without 
NetoU co-expressed, lifetimes of ]]X and WW[Y µs were obtained, which corresponds to 
distances of [\ ± V.XW Å and d[ ± W.] Å. Under glutamate-bound conditions without 
NetoU co-expression the lifetimes obtained were dUX and WVdW µs, which corresponds 
to distances of [V ± V.[W Å and dW ± W.[f Å. These distances are different than those 
obtained previously using cryo-EM; however, the faster lifetime corresponding to [V Å 
fits well in the cryo-EM models, while the longer lifetime corresponding to dW Å is 
significantly shorter than expected, as seen in Figure Wb. It is also important to note 
that at this site it is not possible to determine if the longer lifetime has contribution 
from the diagonal distance between sites being measured (see Figure Wb). 
Under apo conditions with NetoU co-expressed the lifetimes were [fX and WVW] 
µs, which corresponds to distances of \X ± V.d\ Å and dV ± W.\ Å, Figure WIb. Under 
glutamate-bound conditions with NetoU co-expression the lifetimes were dV\ and 
WVdd µs, which corresponds to distances of [V ± V.\U Å and dW ± W.U Å. These data show 
a decrease in distance between ABD dimer pairs when co-expressed with NetoU. This 
indicates that NetoU induces a tighter packing of the ABD layer and likely explains the 
gain in function by conferring additional support between the dimer pairs.  
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Figure 30. Structural model of a homomeric kainate receptor showing site 458. 
(Upper panel) top-down view of homomeric GluK2 with site 458 shown as black 
spheres. (Lower panel) geometry of distances between site 458. 
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Figure 31. Agonist-binding domain LRET acceptor decay plots with double 
exponential lifetime fits. 
 (A) Construct GluK2*458C measured under apo conditions (black) and glutamate-
bound conditions (red). (B) Construct GluK2*458C co-expressed with Neto2 measured 
under apo conditions (black) and glutamate-bound conditions (red). 
 
 
 
a b 
 
104 
 
Cryo-electron microscopy studies of the KAR-Neto complex 
 
Styrene maleic acid solubilization 
As previously discussed, there are experimental difficulties in studying the 
KAR-Neto complex which result from the inability to create a tandem construct for 
characterization. The concern results from the inability to ensure that all of the KARs 
are paired with Neto proteins. When using detergent to solubilize proteins, the 
detergent molecules typically displace the lipids and proteins interacting with the 
receptor at the membrane. This problem can be overcome through the use of styrene 
maleic acid (SMA) to solubilize the complex. Previous studies have shown that 
receptors solubilized in SMA not only retain a disk of lipids surrounding the protein, 
they retain the native lipids normally associated with the proteins (UVd, UV]). 
   
 
Solubilization of KRAS 
 There are a number of structural models and molecular dynamic simulations 
published for KRAS proteins; however, resolving functionally relevant conformational 
states has been limited by their functional requirement for a bilayer. Therefore, the 
data available for KRAS proteins makes it an ideal protein to validate and optimize a 
protocol for SMA solubilization.  In order to optimize a SMA purification protocol for 
use in smFRET and cryo-EM, experiments characterizing the membrane protein KRAS 
using smFRET were performed. 
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The mammalian RAS family of proteins includes the isoforms NRAS, HRAS, 
and KRAS. RAS proteins are GTP signaling proteins tethered to the inner side of the 
plasma membrane. After binding GTP, RAS proteins transduce extracellular signals to 
the nucleus through signaling cascades. KRAS has become of particular interest for its 
potential in treating cancer due to studies showing that mutations altering its GTP 
activity lead to a variety of cancers (UVf, UVY). 
The structure of KRAS proteins is composed of a bi-lobed catalytic domain and 
a flexible C-terminal hypervariable region containing a polybasic and farnesylated 
lipid anchor. It is known that the KRAS catalytic domain can also interact with anionic 
model membranes in three orientation states (OS). OSW involves interactions with a-
helices \-d on lobe U. OSU involves interactions with b-strands W-\ on lobe W, and OSV 
in which a-helices are perpendicular to the membrane. The OSW and OSU 
conformations show different accessibility to the b-stand loops critical for 
coordination with downstream signaling proteins, which suggests the KRAS signaling 
could be modulated by membrane reorientation (UVX, UWV). However, currently only 
inferences can be made from MD simulations and indirect spectroscopic techniques in 
simple model membranes (UVX-UWU). 
In these studies, we characterize the dynamic interactions between the 
catalytic domain of KRAS and membrane lipids using a combination of atomistic MD 
simulation and single-molecule fluorescence resonance energy transfer (smFRET). 
Given the importance of the lipid membrane to KRAS structure, these experiments 
were conducted with KRAS solubilized in styrene maleic acid nanodiscs. 
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 MD simulations were run and the distance between residue W\U on lobe U of the 
catalytic domain and residue WY\ on the C-terminal were analyzed. The MD 
simulations yielded results showing three dominant KRAS orientations with distances 
of WX, \\ and [X Å between sites W\U and WY\, corroborating the \ state model including 
OSW, OSU and OSV. However, the short timescales of the MD simulations limited the 
number of transitions between different orientations. Therefore, smFRET 
measurements were made to help resolve the frequency of transitions between the 
different orientations. The smFRET efficiency histogram for GWUV-KRAS is shown in 
Figure WT.  Efficiency peaks were found centered at V.[V, V.f[, and V.X[. These FRET 
efficiencies correspond to distances of [X, \X, and UX Å, which are very similar 
distribution to the distances obtained with MD simulations. These results indicate 
that the SMA purification strategy is sufficient to isolate the KRAS protein into 
nanodiscs suitable for use in biophysical characterization. These results showed 
promise in utilizing SMA for purification of the KAR-Neto complex, and that process 
was investigated further. 
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Figure 32. Representative trace and efficiency histogram for KRAS FRET 
construct. 
(A) FRET efficiency (EA) histogram fitted to three Gaussians, indicating three distinct 
conformational states, with the high FRET state in blue, mid-FRET state in green, and 
low FRET state in red. A representative EA trajectory indicating fast transitions 
between states is shown as an inset, with the observed signal in red and state 
transitions highlighted in black. 
 
 
 
A 
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Purification and imaging of the GluK2-Neto2 complex 
Characterizing the structural arrangement and molecular interactions between 
GluKU and NetoU would be best accomplished using cryo-EM imaging. There are now 
several molecular models for the AMPA receptor in complex with its auxiliary proteins 
resolved using cryo-EM, but no structural data is available for the KAR-Neto complex. 
Therefore, the purification strategy optimized for the KRAS protein was adopted for 
use with the KAR-Neto complex.  
Initially, the KAR-Neto complex was expressed and purified using HEKUX\T 
cells; however, the yields obtained from this expression system were inadequate for 
cryo-EM imaging. Therefore, the insert containing the GluKU and NetoU constructs 
were separately cloned into pFastBacW vectors to be used in the generation of 
baculovirus. The baculoviruses generated were then used to co-transfect SFX insect 
cells in order to produce high quantities of the GluKU-NetoU complex. 
The SMA purification strategy optimized for the KRAS protein was then 
adapted to a double purification scheme. For affinity chromatography purposes, the 
GluKU construct included a hexa-histidine tag and the NetoU construct included a 
FLAG tag. After SMA solubilization, the SFX cell lysates were applied to a Ni-NTA 
resin and followed by elution using imidazole. Next the eluate was applied to a anti-
FLAG resin, washed and eluted using \X FLAG peptide. Both GluKU and NetoU were 
clearly detected in the double purified eluate on western blots and ran as a single band 
on a native page gel, see Figure WW. 
The samples obtained following the double FLAG and His purification were 
then imaged on a Technai G2 Polara cryo-electron microscope. The microscopy 
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resulted in successful imaging of the receptor; example micrograph shown in Figure 
WY. The receptors appear as tetrameric Y-shaped molecules, similar to what has 
previously been described. 
While these initial micrographs were promising, there were difficulties in 
producing a signal oligomeric species with the purification protocol. The eluate 
obtained from purification likely contains a mixture of various oligomeric states of the 
complex. This is commonplace when purifying oligomers for structural imaging and 
gel filtration chromatography is the traditional method for separating the different 
oligomeric species. The yield obtained from the double purification was typically in 
the V.W-V.[ mg/ml range. However, the yield following gel filtration chromatography 
dropped to between V.VVd-V.VW mg/ml. The UV chromatograph also showed that the 
majority of the protein was either retained in the column or exited in the void volume 
as aggregate. Therefore, additional work must be done refining the purification 
strategy to obtain samples that are homogenous enough to move forward with image 
analysis. 
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Figure 33. Representative SDS and native PAGE gel imaging.  
Representative SDS-page imaging using anti-GluK2 and anti-Neto2 antibodies. 
Representative blue native page gel imaging using silver stain. 
 
 
 
 
 
 
BN-PAGE   | silver stain   | Single band 
SDS-PAGE | α-FLAG IB | Neto2 
HIS/FLAG double purified fraction 
SDS-PAGE | α-HIS IB     | GluK2 
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Figure 34. Representative cryo-EM micrograph. 
(a) Representative cryo-electron micrograph of the GluK2-Neto2 purified fraction on a 
holey carbon grid. (b) Enlarged area from the micrograph showing the KAR-Neto2 
complex. 
a 
b 
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Discussion  
 The LRET experiments presented show that Neto2 modulation affects the 
conformational arrangement of the ABD layer. Neto2 co-expression produced 
measurements with shorter distances between dimer pairs, indicating the ABDs are in 
a more tightly packed arrangement. These are intriguing data showing that, not 
surprisingly, KAR kinetics are being modulated by altering the conformation and 
therefore the dimer interface interactions. Unfortunately, the mutations required for 
LRET experiments nullified the function of the receptor when positioned to measure 
within the ABD layer. Therefore, it could not be determined that the structural effects 
we found are relevant to the true function involved in Neto2 modulation or if they 
arise from misfolding introduced through the mutated residues. These limitations are 
not a concern for investigations utilizing smFRET and these experiments will be 
performed. 
 The strategy for purification of the KAR-Neto2 complex has produced 
promising results; however, the problems in obtaining high-yield samples following 
gel filtration chromatography have limited the progress made imaging the complex. 
These studies are currently being continued through a collaborative effort with 
Columbia University and preliminary results look promising.  
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Chapter 9: Conclusions and Future Directions 
The work presented herein contributes to our understanding of the structure 
function relationship in kainate receptors. Prior to these studies, there were no data 
characterizing the structural dynamics of either full length homomeric or heteromeric 
kainate receptors. Here we used a combination of LRET and smFRET to reveal the 
underlying structural dynamics that drive kainate receptor function and modulation 
by ions and auxiliary proteins. The data we obtained are consistent with many of the 
previous studies regarding kainate receptor gating, ion modulation and auxiliary 
protein modulation. However, our findings regarding the dynamics of the glutamate-
bound state refine our understanding iGluR gating.  
These studies show that unlike what is seen in the AMPA receptor, the ATDs of 
the homomeric and heteromeric KAR maintain relatively low dynamics and remain in 
close proximity throughout the gating cycle. We show that the ABDs retain a tightly 
coupled dimer interface under apo conditions which agrees with previous structural 
studies. We show for the first time in kainate receptors that the ABDs remain tightly 
coupled during the active state and that separation at the dimer interface is the 
initiating step for entry into the desensitized state. Interestingly, the glutamate-bound 
data confirm the previously-hypothesized existence of multiple receptor states. In 
addition, the data show that the higher FRET states are favored indicating that the 
extreme decoupling seen in current KAR models is likely an artifact of the purification 
process for cryo-EM. This finding stands in contrast to our current understanding of 
KAR desensitization, yet is in agreement with a previous study suggesting that 
decoupling at the ABD dimer interface is not required for gating. 
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The heteromeric studies show that the ATDs occupy similar distances and 
dynamics between homomeric and heteromeric KARs and are in agreement with 
previous structural studies. The ABDs, however, show significant differences between 
homomeric and heteromeric receptors with the heteromer showing decoupling in 
both the apo and glutamate-bound states. The decoupling found in the heteromeric 
glutamate-bound state shows less preference for the more coupled interface as 
compared to the homomeric receptor.  These structural differences are in agreement 
with functional differences seen between homomeric and heteromeric KARs, showing 
more rapid entry into the desensitized state in heteromers. 
The investigations into the structural effects of Neto modulation show that, 
similar to what is found in the AMPARs, the auxiliary protein is reorienting the ABD 
dimer pairs into a more compact arrangement. A reorientation of this nature would 
affect the stability of the ABD dimer interface and explains the gain in function 
resulting from Neto co-expression. Collectively these experiments highlight the 
importance of the ABD dimer interface in receptor function. 
As discussed and examined throughout this dissertation, the interface within 
the ABD dimers is critical for receptor function. The current model of iGluR gating 
puts the decoupling of the ABD dimer interface as the major driving force regulating 
receptor kinetics. While the ABD interface is certainly the most important site 
regulating gating kinetics, the decoupling previously found in KAR models is not 
corroborated by our data nor by structural models of the AMPA receptor co-expressed 
with auxiliary proteins. In both the homomeric and heteromeric studies, distances 
corresponding to current structural models are found but represent the least favored 
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state. This finding highlights the importance of characterizing the dynamics of 
proteins under conditions more similar to what the receptor experiences in its native 
environment. While imaging the receptor under crystalized or vitrified conditions is 
critical for understanding the tertiary and quaternary arrangement of the proteins, it is 
insufficient for accurately resolving structural dynamics and the conformational 
arrangements involved with function.  
Given the difficulties in obtaining high resolution KAR models and the 
inherently dynamic nature of iGluRs, it seems clear that a combination of static and 
dynamic experimentation is required for a comprehensive understanding of 
mechanisms underlying the processes of activation and desensitization. The work 
presented in this dissertation advances our understanding of KARs by combining 
previously resolved structural models with physiologically relevant conformational 
states and the dynamics of the full-length homomeric and heteromeric KAR. The 
combination of these data makes it possible to more accurately model receptor 
behavior using MD simulations and identify topological chemistries ideal to 
discriminate between iGluR subtypes and KAR subunit compositions. The advances in 
knowledge made through these studies bring the possibility of introducing novel 
therapeutic drugs targeting iGluRs closer to reality.  
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Future directions 
While these data progress our understanding of the structure/function 
relationship in KARs, significant work remains to be done. KARs have consistently 
proven to be difficult receptors to work with in regard to advancing our understanding 
of their molecular structure and mechanisms. However, our laboratory is well 
positioned to unite the most cutting-edge structural dynamic experimentation with 
static models to resolve these difficult questions. 
 
Further investigations into the agonist-binding domain 
The experiments performed here on the ABD identify the one-dimensional 
changes in distance relevant to receptor function in homomeric and heteromeric 
KARs. In the homomeric receptor, we were limited to measurements being made 
across the dimer interface near site [fX due to the convoluting effects of having the 
labeling site on all four subunits. While these measurements are critical for 
understanding the dynamics at this interface, it cannot resolve the \-dimensional 
movements of this domain in homomeric KARs. 
The heteromeric receptor provides a platform in which a series of one-
dimensional measurements made from different positions within the ABD and 
between the ABD and ATDs can be made. While only measurements complementary 
to the homomeric site have been made thus far, additional points of measurement are 
not restricted as in the homomeric receptor. Further studies performed on additional 
sites within the ABD, between the ABD and the ATD, and measurements made 
between the ABD and lipids would integrate the \-dimensional movements within the 
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protein complex, providing a complete picture of the dynamic landscape to be used as 
constraints in MD simulations. 
 
Neto interactions at the amino-terminal domain 
The KAR amino-terminal domain has received the least attention of all the 
domains. As previously discussed, there are no allosteric regulatory effects found in 
the ATD and very little dynamics are shown. Our data align with previous studies 
identifying the ATD’s involvement in Neto trafficking, which is significant for receptor 
function. Currently only LRET studies have shown that Neto co-expression 
significantly alters the conformational arrangement of the ATDs. Further experiments 
utilizing smFRET to characterize the effect of Neto proteins on the ATD should be 
performed. smFRET measurements made between ATD dimers and within the ATD 
dimer pairs would verify the altered conformation observed using LRET. Additionally, 
smFRET measurements made between the ATDs and different CUB domains within 
the Neto proteins could be used to triangulate the position of Neto proteins relative to 
the receptor; similar to what our laboratory has previously done with the AMPA-
stargazin complex.  
 
A closer look at the transmembrane domain 
Of the ordered domains of KARs, the transmembrane domain has been most 
difficult to study due to experimental limitations. In the homomeric KAR it is not 
possible to make LRET or smFRET measurements in this region due to its small 
radius. However, as seen in this dissertation, the heteromer allows for measurements 
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to be made in this domain. Measurements characterizing the effect of Neto 
modulation would be of great value given that studies have shown that residues just 
above the transmembrane helices are critical for Neto modulation. 
 
The carboxyl-terminal domain 
The CTD remains the most mysterious region of KARs due to their intrinsically 
disordered nature. While it is unlikely that detailed crystallography or cryo-EM 
models will resolve this region, smFRET could provide detailed insight into this 
question. Fluorescent proteins have already been used in FRET experiments on CTD 
position and smFRET with organic fluorophores would increase the resolution 
significantly. Experiments measuring the dynamic effects of calmodulin and many 
other intracellular signaling proteins binding to the CTD would shed light on the 
structure-function relationship of this domain for the first time. 
 
Neto proteins and modulation 
 We have shown that Neto proteins affect the orientation of the ABD and ATD 
using LRET. Yet the mechanisms mediating their interaction, their sites of interaction 
and the conformational arrangement of the Neto proteins remain in question. 
Fortunately, there are a number of structural studies performed on CUB domain-
containing proteins homologous to Neto proteins. Given that we have structural 
insight into CUB domains, and the tertiary structure of those domains is highly 
conserved, these questions can and should be addressed using smFRET. smFRET 
measurements made within and between the CUB domains when bound to the KAR 
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would resolve the structural arrangement of Neto proteins. Additional measurements 
made between the Neto protein and the KAR ATD and ABD would reveal the 
architecture of the KAR-Neto complex. Importantly, these data would provide a 
complementary view of the complex to be compared to the cryo-EM structure of the 
complex when it becomes available.  
 
New technologies for the study of membrane protein complexes 
Cell signaling is one of the most important physiological functions in biology. 
Given that signaling involves transducing a signal across a membrane, it is no surprise 
that the majority of proteins involved in signaling cascades are membrane proteins. 
Difficulties in studying membrane proteins arise from their transmembrane 
architecture. Solubilizing membrane proteins for studies requires the use of 
amphipathic molecules to bind their hydrophobic TM regions. Traditionally 
detergents are used for solubilization; however, the nature of detergent and the 
concentration used needs to be precisely optimized for success. 
In recent years, membrane scaffold protein (MSP) and SMA copolymers have 
been used to more efficiently solubilize membrane proteins. MSPs are advantageous 
in that they allow for relatively precise control of the nanodisc size obtained; however, 
they typically require prior solubilization into detergent. SMA, on the other hand, 
allows for the direct solubilization of membrane proteins from native membranes. 
This retains the native lipid environment and keeps the receptor associated with other 
membrane proteins. Structures have been published using SMA solubilized samples 
and have shown the utility of SMA while removing the need for time consuming 
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detergent screening. Given the success of previous studies and our own SMA 
purification, it seems that SMA has a bright future in structural biology. 
More recently, developments in fluorophore and microscope technology have 
increased the power of smFRET measurements to operate with four fluorescent 
molecules, termed four-color FRET. This is groundbreaking technology in that it 
converts the single dimensional measurement obtained in traditional FRET 
measurements into multidimensional measurements. Experiments utilizing four color 
FRET are able to quantitate the allosteric motions involved in complex protein 
complexes in single measurements. iGluRs serve as a perfect subject for four color 
FRET and, if used in combination with the ever-increasing power of MD simulations, 
will revolutionize our view into the dynamics of the molecular world. 
 
Final thoughts 
Kainate receptors are fascinating and yet underappreciated proteins which, 
along with other ionotropic receptors, have been instrumental in the evolution of 
cognition in vertebrate species. The work presented in this dissertation has increased 
our understanding of the structure-function relationship of kainate receptors, yet 
much remains to be discovered. However, as computational technology and scientific 
techniques continue to evolve, the mysterious link between synaptic transmission, 
neural oscillation patterns, and cognition will be revealed.  
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Appendix: Materials and Methods 
Homomeric Studies 
Parts of this section are based upon research originally published in Scientific 
Reports. Litwin, D. B., E. Carrillo, S. A. Shaikh, V. Berka, and V. Jayaraman. The 
structural arrangement at intersubunit interfaces in homomeric kainate receptors. 
Scientific Reports. UVWX; X(W):]X]X © Springer Nature Publishing AG. 
 
Generation of FRET mutants 
The R. norvegicus GluKUEM construct (U], UX) was kindly provided by Dr. Mark 
Mayer and retained the native glutamine at site dXV. The coding sequence for GluKU 
was PCR amplified and inserted into pcDNA\.W. Mutations were introduced using 
standard PCR-based mutagenesis methods. To create the background construct 
GluKU*, non-disulfide-bonded cysteines at sites CXW, CWXX, C[\U, were mutated to 
serines. On this background two constructs were made; one with SU]] mutated to 
cysteine and one with A[fX mutated to cysteine. A third construct was made in which 
both A[fXC and Dff]K mutations were introduced.  
 
 
Electrophysiology 
Mutant HEK UX\T cells were transfected using jetPRIME PolyPlus (wt-GluKU, 
GluKU*SU]]C, and GluKU*A[fXC) or lipofectamine UVVV Invitrogen (GluKU*A[fXC-
Dff]K), and were, in both conditions, co-transfected with GFP at a microgram ratio of 
\:W per WV ml of media. After [-] h of incubation, cells were re-plated (\V mm dishes) 
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at low density. Cells were labeled in dish with [VV nM of donor fluorophore Alexa ddd 
maleimide (ThermoFisher) and [VV nM of acceptor fluorophore Alexa ][f maleimide 
(ThermoFisher) in U mL extracellular buffer pH f.[ (WdV mM NaCl, W.Y mM MgClU, W 
mM CaClU, \ mM KCl, WV mM glucose, and WV mM HEPES). Whole cell patch clamp 
recordings were performed U[-[Y h after transfection, using fire-polished borosilicate 
glass (Sutter instruments) pipettes with \-d mΩ resistance, filled with internal 
solution: WWV mM CsF, \V mM CsCl, [ mM NaCl, V.d mM CaClU, WV mM HEPES, and d 
mM EGTA (adjusted to pH f.[ with CsOH). The external solutions containing WdV mM 
NaCl or CsCl, U.Y mM KCl, W.Y mM CaClU, W.V mM MgClU, and WV mM HEPES (adjusted 
to pH f.[ with NaOH or CsOH) were (without and with WV mM glutamate) applied to 
lifted cells using a stepper motor system (SF-ffB; Warner Instruments) with triple 
barrel tubing. Recordings were performed using an Axopatch UVVB amplifier 
(Molecular Devices) at −]V mV hold potential, acquired at WV kHz using pCLAMPWV 
software (Molecular Devices), and filtered online at d kHz. 
 
 
LRET sample preparation 
HEK293T cells were transiently transfected according to JetPrime protocol at 10 µg per 
10 cm plate and maintained in DMEM. For LRET measurements, cells were transfected 
with a GluK2 construct alone. Cells were collected and washed three times using 
extracellular buffer containing 160 mM NaCl, 1.8 mM MgCl2, 1 mM CaCl2, 3 mM KCl, 
10 mM glucose, and 10 mM HEPES (pH 7.4). The washed HEK cells were then labeled 
with 400 nM donor and 100 nM acceptor fluorophores in 3 ml extracellular buffer, 
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rotating at room temperature in the dark for 1 hr. The donor fluorophore was terbium 
chelate (Invitrogen), and the acceptor fluorophore was fluorescein maleimide 
(Thermo Fisher Scientific) for cysteine mutants. After labeling, cells were washed and 
resuspended in 2 ml extracellular buffer and used for LRET measurements. 
Extracellular buffer used in Cs+ substitution experiments contained 150mM CsCl in 
place of NaCl. 
 
LRET data collection 
A cuvette-based system consisting of a fluorescence lifetime instrument (EasyLife 
L;Hoiba) and analysis software (Fluorescan 5.5; Optical building blocks) was used for 
LRET measurements. All samples were excited at 337 nm. Emission was detected at 
545 nm for donor-only samples, at 515 nm for fluorescein-labeled samples. LRET 
measurements were taken in triplicate for a given condition followed by scans after 
Factor Xa protease cleavage to quantitate the samples’ background signals without the 
labeled receptors’ contribution to the signal. Fluorescent decay plots obtained for 
given conditions and the background for that condition were then plotted in Origin 
and averaged, and the background was subtracted from the full signal. Following 
background subtraction, the resulting decay plots were fit to double exponential decay 
functions thereby quantitating the decay lifetime of the acceptor fluorophore. Error in 
the distance estimates was then calculated by propagating the errors in the donor and 
acceptor lifetimes using the Error Propagation Calculator developed by Thomas Huber 
in the Physics Department of Gustavus Adolphus College. Lifetimes were quantitated 
for samples labeled with only the donor (tD) and samples labeled with both donor and 
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acceptor (tDA), to be used to calculate the distance between the fluorophores using the 
Forster equation: 
𝑹 = 𝑹𝟎(
t𝑫𝑨
	t𝑫 − t𝑫𝑨
)𝟏 𝟔;  
where R is the distance between donor and acceptor fluorophore, R0 is the distance 
yielding half-maximal energy transfer for a given fluorophore pair (45 Å  for terbium-
fluorescein), tD is the measured lifetime of the donor when bound to the protein and 
without acceptor fluorophore present, and tDA is the lifetime of the donor fluorophore 
when bound to the protein and transferring energy to the acceptor fluorophore, which 
we have measured here as the lifetime of the sensitized emission of the acceptor. For 
LRET experiments, the number of biological replicates for apo, glutamate, apo-CsCl,  
and glutamate–CsCl was, respectively, n = 3. Final lifetime values for given conditions 
were obtained by averaging the Background-subtracted lifetime values per day. 
 
smFRET sample preparation 
HEKUX\T cells were transiently transfected according to JetPrime protocol at 
WV µg per WV cm plate. One day post-transfection, cells from two WV-cm dishes were 
harvested and washed with extracellular buffer and labeled for W h at room 
temperature with [VV nM of donor fluorophore Alexa ddd maleimide (ThermoFisher) 
and [VV nM of acceptor fluorophore Alexa ][f maleimide (ThermoFisher) in \ mL 
extracellular buffer. This concentration of fluorophore was determined to be optimal 
for single donor and single acceptor labeling. After washing, labeled cells were then 
solubilized for W h at [ °C in solubilization buffer consisting of phosphate-buffered 
saline, W% lauryl maltose neopentyl glycol (MNG-\) (Anatrace), U mM cholesteryl 
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hydrogen succinate (MP Biomedicals), and ¼ protease inhibitor tablet (Pierce). 
Unsolubilized debris were then spun down for W h at WVV,VVV × g at [°C, and the 
supernatant used as the smFRET sample. Samples were then diluted W:U in cold SB 
before application. 
 
 
smFRET flow chamber preparation 
Coverslips (UU × UU mm No. W) were washed with Liqui-Nox phosphate-free 
detergent (Alconox Inc.) and [.\% NH[OH and [.\% HUOU. Coverslips were then 
plasma cleaned using a Harrick Plasma PDC-\UG Plasma Cleaner and then 
aminosilanized through Vectabond treatment (Vector Laboratories). A circular area 
on the slide was then isolated using Silicone templates (Grace bio-Labs) and treated 
with a PEG solution containing d kDa biotin-terminated PEG (U.d% w/w in molecular 
biology grade (MB) water, NOF Corp.), and d kDa mPEG succinimidyl carbonate (Ud% 
w/w in MB water, Laysan Bio Inc.) in V.WM sodium bicarbonate (Sigma-Aldrich) 
overnight in a dark and moist environment. On the day of the experiment, the 
coverslips were washed with PBS, treated with short chain \\\ Da NHS-ester PEG 
(Thermo Scientific) and incubated for U–\ h. Slides were then washed and dried with 
NU gas. A chamber was then constructed over the treated circular area by applying 
hybriwell chambers (Grace bio-Labs) then dual silicon press-fit tubing connectors 
(Grace bio-Labs). 
 
 
 
126 
 
smFRET protein preparation and attachment to coverslip 
Streptavidin was applied to the chamber by flowing \U µl of a buffer solution 
containing phosphate-buffered saline (PBS), W mM DDM (n-dodecyl-β-D-maltoside), 
V.U mM CHS (cholesteryl hydrogen succinate), and V.U mg/mL Streptavidin through 
the flow chamber and incubating for WV min. WVnM of biotinylated goat Anti-Rabbit 
IgG (H+L) secondary antibody (Jackson Immunoresearch Laboratories, Inc., cat. no. 
WWW-V]d-VV\) was then flowed into the chamber, incubated for UV–\V min, then 
washed with PBS. Next, WV nM of anti-GluKU (C-terminal epitope) mouse monoclonal 
primary antibody (Abcam, cat. no. abWd\Vf) was flowed in, incubated for UV–\V min, 
and washed with PBS. This antibody was chosen as it is far from the extracellular sites 
being studied. Detergent solubilized HEKUX\T cell membranes containing GluKU 
receptors were then bound to a glass slide using the in situ immuno-precipitation 
(SiMPull(UW\)) method for FRET data acquisition. ]V μL of the sample was applied 
twice through the chamber followed by a UV–\V min incubation before flushing the 
chamber with ]V µl oxygen scavenging solution buffer system (ROXS) buffer twice. 
ROXS buffer used consisted of W mM methyl viologen, W mM ascorbic acid, V.VW% w/w 
pyranose oxidase, V.VVW% w/v catalase, \.\% w/w glucose (all from Sigma-Aldrich), W 
mM DDM (Chem-Impex), and V.U mM CHS (MP Biomedicals, LLC) in PBS, pH f.[. W 
mM glutamate was added and/or WdV mM CsCl was used to replace NaCl in the ROXS 
to achieve the experimental conditions and WmM UBP\WV was included for antagonist-
bound experiments.  
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smFRET data acquisition  
For Single molecule FRET measurements were acquired using a custom-built 
PicoQuant MicroTime UVV Fluorescence Lifetime Microscope. smFRET data 
acquisitions were conducted using pulsed interleaved excitation at YV MHz. Both d\U 
nm (LDH-D-TA-d\V; Picoquant) and ]\f nm (LDH-D-C-][V; Picoquant) lasers were 
simultaneously used to characterize the fluorescent behavior of both fluorophores and 
the efficiency of energy transfer between molecules potentially showing FRET. The 
sample slide was immobilized on a scanning x-y-z piezo stage (P-f\\.UCD; Physik 
Instrumente) while being excited and observed through a WVVx oil immersed lens 
(WVV× W.[ NA; Olympus). The photons emitted from the sample post-excitation were 
collected back through the objective, separated through a dual band dichroic beam 
splitter (Ztd\U/][Vrpc-UF\; AHF/Chroma) and sent to two SPAD photodiodes (SPCM 
CD\dW]H; Excelitas technologies) preceded by excitation filters. A ddV nm (FFVW-
dYU/][;AHF/Semrock) and ]dV nm (UXH]XV/fV;AHF) emission filter were used for 
the donor and acceptor channels, respectively. All acquisitions were performed in the 
presence of a photo-stabilizer and oxygen scavenging solution buffer system (ROXS).  
 
smFRET molecules selection and analysis 
Since the kainate receptors studied here are homomeric, there is a distribution 
of various donor/acceptor combinations. To exclude signal from those channels 
having multiple donors or multiple acceptors, the fluorescence intensity of single 
channels and the step-wise photobleaching was studied. Multiple donors or acceptors 
have multiple photobleaching steps and these traces were not used. The number of 
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photobleaching steps per molecule in the U]] and [fX data sets exhibited the 
following distribution: WV% showed four steps, dV% showed three steps, \d% showed 
two steps, and d% showed one step. The FRETing regions of the smFRET traces 
obtained for all constructs were on average W to \ seconds in length. Only the traces 
with a clear single photobleaching step in both donor and acceptor channels were 
included in the analysis. This molecule hence reports on a single distance between 
single donor and single acceptor. Such a strategy has been used successfully by us as 
well as several other laboratories (W\[, WdY, UW[, UWd).  
 
The fluorescence intensity of the donor and acceptor (upon excitation of 
donor) were used to calculate FRET efficiencies as described in these references (W\[, 
Wdd-WdY, W]V, WfV, WfY). The photon counts produced per donor and acceptor excitation 
were acquired at W ms resolution, binned to d ms, and denoised with wavelet 
decomposition, and the calculated efficiencies were then plotted as separate 
histograms showing the occurrence of photons at their observed FRET efficiencies. 
Each count in the histogram represents one d ms bin, with the cumulative of all such 
counts from all the molecules normalized.   
  
The number of states that best describes the distribution of FRET efficiencies 
found in the obtained FRET data was then determined using Step Transition and State 
Identification (STaSI) analysis (WYV) and hidden Markov modeling using HAMMY 
(WfX) and fit to Gaussian distributions. 
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While we have provided distances based on the smFRET intensities it should 
be noted the distances are between the fluorophores and hence the size and length of 
the fluorescent probes brings additional errors in the estimation of distances. Thus we 
focus on the change in distances and heterogeneity between the different states being 
studied. This is a reasonable assumption as the size of the probes is not expected to 
change between the states being studied. Furthermore, the heterogeneity and 
transitions across states are evident in the single molecule traces where a given donor-
acceptor pair is being probed.  
 
Free energy calculations  
The free energy of the most populated state identified by STaSI analysis was set to V 
kBT. The percent occupancies as determined by STaSI were then used to calculate the 
equilibrium constant Keq between states, and the free energy of every state relative to 
the most populated state was determined using the equation:  
 
∆Gb =−kBT lnKeq 
 
The transition probabilities between each pair of states, given our d ms bin time, was 
used to determine the reaction rate for each transition, and the heights of the energy 
of activation barriers were calculated assuming a first-order reaction rate and using 
the Arrhenius equation:  
 
k = Ae−Ea /kBT 
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Where k is the rate constant, the concentration of the starting state was taken as the 
STaSI-derived fractional occupancy of that state, and the value of the pre-exponential 
was chosen to be WV ms−W. Forward and reverse energies of activation were averaged in 
the final figure. 
 
Statistics 
Data were analyzed using Origin (OriginLab Corp.), MATLAB (MathWorks), 
and Excel (MicrosoftCorp.). For smFRET experiments, the numbers of molecules that 
passed cross- and anti-correlation checks for A[fXC-apo, A[fXC-glutamate, A[fXC-
apo-CsCl,  A[fXC-glutamate–CsCl, SU]]C-apo, SU]]C-glu, Dff]K-glutamate, Dff]K-
glutamate- CsCl, SU]]C-UBP\WV and A[fXC-UBP\WV were, respectively, n = df, ]], dd, 
dU, [f, dV, [f, dd, UX and UY.  
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Heteromeric studies 
Parts of this section are based upon research originally published in Biochimica 
et Biophysica Acta- Biomembranes. Litwin, D. B., N. Paudyal, E. Carrillo, V. Berka, and 
V. Jayaraman. The structural arrangement and dynamics of the heteromeric 
GluKU/GluKd kainate receptor as determined by smFRET. Biochimica et Biophysica 
Acta- Biomembranes. UVWX; DOI: WV.WVW]/j.bbamem.UVWX.Vd.VU\ © Elsevier B.V. 
 
Homology modeling  
\ homology structures were made for heteromeric GluKU/GluKd. U models were built 
based on homomeric GluKU one in antagonist bound form (PDB dKUF) and other in 
agonist-bound form exhibiting desensitized state (PDB:dKUH). These models were 
built using SWISS MODEL server accessible via EXPASy web server (UW]). The third 
model was built based on the antagonist bound AMPA structure (PDB:\KGU). This 
model was built using MODELLER software (UWf) . Antagonist bound structures 
represent closed state similar to apo structure and hence are used for the analysis of 
apo state. 
 
Generation of FRET constructs 
The R. norvegicus GluKU construct used previously in cryo-EM (U], UX) and 
smFRET (UVV) experiments was used and retained the native glutamine at site dXV. 
The GluKU coding sequence was PCR amplified and inserted into pcDNA\.W. The 
background GluKU FRET construct was created by mutating the non-disulfide bonded 
cysteines CXW, CWXX and C[\U to serines. From this background five constructs were 
 
132 
 
created. One with SU]] mutated to cysteine, one with A[fX mutated to cysteine, one 
with SdU\ mutated to cysteine, one with both A[fXC and Dff]K mutations, and one 
with both SdU\C and Dff]K mutations. 
The R. Norvegicus construct containing GluKd was kindly provided by Geoffrey 
Swanson, PhD. The GluKd coding sequence was PCR amplified and inserted into 
pcDNA\.W. The background GluKd FRET construct was created by mutating the 
cysteines CW[, CYY and CUfV to serines. From this background five constructs were 
created. One with SU]d mutated to cysteine, one with A[fW mutated to cysteine, one 
with SdWd, one with both A[fWC and Dff]K mutations and one with both SdWdC and 
Dff]K mutations. 
 
Electrophysiology  
HEK 293T cells at 30% confluency were transfected using lipofectamine 2000 
(Invitrogen) with GluK2 and GluK5, co-transfected with GFP at a microgram ratio of 
1:4:0.5. Whole cell patch clamp recordings were performed 24-48 h after transfection, 
using firepolished borosilicate glass (Sutter instruments) pipettes with 3-5 mΩ 
resistance, filled with internal solution: 110 mM CsF, 30 mM CsCl, 4 mM NaCl, 0.5 mM 
CaCl2, 10 mM HEPES, and 5 mM EGTA (adjusted to pH 7.4 with CsOH). The external 
solutions contained 150 mM NaCl, 2.8 mM KCl, 1 mM CaCl2 and 10 mM HEPES 
(adjusted to pH 7.4 with NaOH). The glutamate (10 mM) was applied to cells using a 
stepper motor system (SF-77B; Warner Instruments) with Triple barrel tubing. 
Recordings were performed using an Axopatch 200B amplifier (Molecular Devices) at 
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−60 mV hold potential, acquired at 10 kHz using pCLAMP10 software (Molecular 
Devices) and filtered online at 5 kHz. 
 
smFRET sample preparation 
HEK293T cells grown on 10cm plates were checked for approximately 50% confluency. 
The cells were then transfected with 20 µg DNA per 10 cm plate following JetPrime 
protocol. DMEM media was changed after four hours of transfection and was left for 
overnight expression. Next day, cells were collected from two transfected 10 cm plates 
and were washed with 3mL of extracellular buffer (ECB). The sample was then 
wrapped in foil and was labeled with 400 nM of Alexa 555 maleimide (ThermoFisher), 
a donor fluorophore and 400 nM of Alexa 647 maleimide (ThermoFisher), an acceptor 
fluorophore, in 3mL ECB at room temperature for 1hr. The labelled cells were washed 
with 3mL ECB and were resuspended in 2mL of solubilization buffer by nutating at 
4°C for one hour. Solubilization buffer consists of phosphate-buffered saline, 1% lauryl 
maltose neopentyl glycol (Anatrace), 2 mM cholesteryl hydrogen succinate (MP 
Biomedicals), and ¼ protease inhibitor tablet (Pierce). The nutated sample was then 
transferred to an ultracentrifuge tube and was spun for one hour at 44000 rpm at 4°C 
using a TLA 100.3 rotor for filtering unsolubilized debris. Supernatant thus collected 
were used as smFRET samples and were kept on ice until they were used.  
 
smFRET slide preparation 
 Microscope glass slides (20 × 20 mm) were cleaned in a solution of Liquinox 
phosphate-free detergent (Alconox Inc.) via bath sonication followed by washing with 
 
134 
 
solution consisting 4.3% NH4OH and 4.3% H2O2. Slides were then washed with purified 
water, dried with nitrogen gas and placed in metal slide holder. Plasma cleaning of the 
slides was done using Harrick Plasma PDC-32G Plasma Cleaner and then the slides were 
treated with Vectabond (Vector Laboratories, CA) for aminosilanization and stored under 
vacuum. Clean silicone templates (Grace bio-Labs) which were bath sonicated, and 
methanol treated were dried using nitrogen flow and were placed at the center of the 
slides. The slides were then treated with 50µl of PEG solution (0.25% w/w biotinylated 
PEG, 25% w/w mPEG-succinimidyl carbonate, 0.1M NaHCO3) and incubated in a dark 
moist environment overnight. On the day of the experiment, after cleaning the slides with 
purified water and dried with nitrogen, slides were applied with short chain PEG solution 
(25mM short-chain 333 Da MS(PEG)4 Methyl-PEG-NHS-Ester Reagent, 0.1 M 
NaHCO3) and were incubated at room temperature for two to three hours. Then, the 
slides were washed with water, dried with nitrogen and silicone templates were removed 
followed by applying Hybridwell chambers and press-fit tubing connectors (Grace bio-
Labs). 36 µl of streptavidin solution (0.2 mg/mL streptavidin, 1×smFRET imaging buffer 
(1mM DDM (n-dodecyl-β-D-maltoside), 0.2mM CHS (cholesteryl hydrogen succinate), 
1×PBS) was applied to the chamber, incubated for 10 minutes and was washed with 
1×PBS. The smFRET sample was then applied to the slide and incubated at 4°C for 20 
minutes followed by washing of slides two times with 60 µl ROXS (reactive oxygen 
species) scavenging solution (3.3% w/w glucose, 0.1mg/mL pyranose oxidase, 0.01 
mg.mL catalase, 1mM ascorbic acid, 1mM methyl viologen and/or 1mM glutamate) 
(Sigma-Aldrich). Finally, the slides were ready for imaging. 
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smFRET data collection 
A PicoQuant MicroTime UVV Fluorescence Lifetime Microscope, a kind of 
confocal microscope, was used for acquiring the smFRET data with pulsed interleaved 
excitation (PIE) set at YV MHz. The fluorophores were excited by using d\U nm (LDH-
D-TA-d\V; Picoquant) and ]\f nm (LDH-D-C-][V; Picoquant) lasers simultaneously. 
The sample slide positioned on a scanning x-y-z piezo stage (P-f\\.UCD; Physik 
Instrumente) was observed through an oil immersed WVVX objective lens (WVV× W.[ NA; 
Olympus). Two SPAD photodiodes (SPCM CD\dW]H; Excelitas technologies) collected 
photons emitted from the sample passing through objective to the emission filters ddV 
nm (FFVW-dYU/][; AHF/Semrock) and ]dV nm (UXH]XV/fV;AHF) to the photodiodes.  
 
smFRET data analysis 
Molecules exhibiting a single donor and single acceptor photobleaching step 
with anticorrelation upon acceptor bleaching were used for analysis. Intensities for 
donor and acceptor were then used for the calculation of FRET efficiencies. MATLAB 
(MathWorks) was used for denoising donor and acceptor traces using wavelet based 
denoising. Origin (OriginLab Corp) was used for obtaining smFRET histograms which 
included overlaid denoised and observed data, and gaussian curve fitting to represent 
FRET states. The total number of molecules used for the analysis of each conditions 
are, UY molecules for GluKU*-U]] - GluKU*-U]], U]-UY molecules for GluKU*-[fX - 
GluKd*-[fW, and Uf-\W molecules for GluKU*-dU\ - GluKU*-dU\ and GluKd*-dWd -
GluKd*-dWd.  
 
 
136 
 
KRAS smFRET studies 
Parts of this section are based upon research originally published in Biophysical 
Journal. Prakash, P., D.B. Litwin, H. Liang, J. Hancock, V. Jayaraman and A. Gorfe. 
Dynamics of membrane-bound GWUV-KRAS from simulations and single-molecule 
FRET in native nanodiscs. Biophysical Journal. UVWX; WW](U): WfX-WY\ © Biophysical 
Society. 
 
Extraction of G12V-KRAS in native NDs 
To measure FRET distance between fluorophore-labeled residues 132 and 183 (ζ∗), we 
generated a hemagglutinin (HA)-His-tagged G12V-KRAS with D132C/T183C/C118S 
mutations (G12V-KRAS∗). In this construct, D132C and T183C provide surface-exposed 
cysteines for site-specific fluorescent labeling, whereas C118S eliminates the only 
surface cysteine to avoid nonspecific labeling. The C118S mutation does not affect 
structure or function (218). Similarly, we do not expect major structural or functional 
effects from mutations at the surface residues D132 or T183. The His tag was added to 
aid surface immobilization, and HA to enhance expression of the Cys mutant KRAS. 
The construct was expressed in baby hamster kidney (BHK), cells grown to 
confluency, and styrene-maleic acid (SMA) extracted in NDs, as follows. Intact cells 
suspended in phosphate-buffered saline (PBS) containing 20 μg/mL 
deoxyribonuclease and 0.5 mM phenylmethylsulfonyl fluoride were treated with 2% 
SMA for 1 h at room temperature under rotation. After ultracentrifugation at 
100,000 × g for 1 h at 4°C, the supernatant containing ND-bound G12V-KRAS∗ was 
collected and quantified using Western blotting. On the day of analysis, the 
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supernatant containing ND-G12V-KRAS∗ was incubated with a 1:4 molar ratio of Alexa 
Fluor 555 (donor) and Alexa Fluor 647 (acceptor) maleimide (Invitrogen, Carlsbad, 
CA) for 1 h at room temperature under rotation. Excess dye was removed using a PD-
10 desalting column (GE Healthcare Life Sciences, Waukesha, WI). 
  
FRET data acquisition and analysis 
The labeled protein was diluted 5× and immobilized on a glass surface for smFRET 
measurements. A custom-built PicoQuant MicroTime 200 Fluorescence Lifetime 
Microscope was used for smFRET measurements at 80 MHz using pulsed interleaved 
excitation. The 532 nm (LDH-D-TA-530; PicoQuant, Berlin, Germany) and 637 nm 
(LDH-D-C-640; PicoQuant) lasers were used to characterize the efficiency of energy 
transfer between molecules potentially showing FRET. The sample was excited and 
observed through a 100× oil immersed lens (100× 1.4 NA; Olympus, Tokyo, Japan) 
while immobilized on a scanning x-y-z piezo stage (P-733.2CD; Physik Instrumente, 
Auburn, MA). The photons emitted from the sample post excitation were separated 
through a dual-band dichroic beam splitter (Zt532/640rpc-UF3; adaptive high 
frequency [AHF]/Chroma, Los Angeles, CA) and sent to two single-photon avalanche 
photodiodes (SPCM CD3516H; Excelitas Technologies, Fremont, CA). The 550 nm 
(FF01-582/64; AHF/Semrock, Rochester, NY) and 650 nm (2XH690/70; AHF) emission 
filters were used for the donor and acceptor channels, respectively. ROXS was used 
during all data acquisitions. The photon counts were acquired at 1-ms resolution, 
binned to 10 ms, denoised with wavelet decomposition, and plotted as separate 
histograms showing the occurrence of photons FRETing at their observed efficiencies. 
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Step transition and state identification (STaSI) analysis was then used to determine 
the number of states that best describes the distribution of FRET efficiencies found in 
the obtained FRET data. The free energy (in terms of kBT) associated with each STaSI-
identified state (ΔG) was calculated by setting the most populated state to 0 kBT and 
using the frequency of state occurrences relative to the most populated state as . 
The energy barriers between states were assumed to be of first-order kinetics and 
calculated using the Arrhenius equation. The concentration of the starting state was 
taken as the STaSI-derived fractional occupancy of that state. Forward and reverse 
energies of activation were averaged. Data were analyzed using Origin (OriginLab, 
Northampton, MA), MATLAB (The MathWorks, Natick, MA), and Excel (Microsoft, 
Tulsa, OK). For smFRET experiments, after filtering out the molecules that failed the 
anticorrelation check, the number of particles was n = 13. 
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LRET and cryo-EM into Neto2 modulation  
 
LRET studies of Neto2 
LRET experiments were prepared and analyzed as previously discussed. 
 
Generation of baculovirus constructs  
The open reading frame containing GluK2 and eGFP used previously in cryo-EM 
experiments (26) was cloned into a pFastBac1 vector using the Gibson Assembly 
method.  The open reading frame for Neto2 was cloned into a pFastBac1 vector using 
the Gibson Assembly method.   
 
P1 baculovirus stock  
Approximately 8x105 SF9 cells were plated into a six well plate and allowed to adhere 
for 20 min. media was aspirated and replaced with plating media (1.5 ml Grace’s insect 
medium- 10% FBS with 8.5 ml Grace’s insect medium) 8 µl of Cellfectin reagent was 
then diluted into 100 µl Grace’s media unsupplemented. 2 µl of bacmid DNA was 
diluted into plating media, then mixed by lightly flicking the tube. The Cellfectin and 
DNA solutions were then mixed and incubated at room temperature for 30 minutes. 
The mixture was added dropwise onto the cells, mixed and incubated at 27°C for 5 
hours. After 5 hours, the media was aspirated and replaced with Graves’s medium + 
10% FBS. After observing 70% of cells lysing, the supernatant was removed, 
centrifuged at 500 x g for 5 minutes and the remaining supernatant was kept as the P1 
stock. Viral titers were determined using 1:10 dilutions and plaque quantitation. P2 
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viral stocks were generated by applying the P1 stock at an MOI of 0.1 to SF9 cells 
seeded at 2x106 cells per well, incubating 48 hours, and collecting the supernatant. 
Again, viral titers were determined using 1:10 dilutions and plaque quantitation. 
 
Expression  
500 ml SF9 suspension cultures were prepared at 1 x 106 cells per ml. P2 viral stock was 
added at an MOI of 1 per construct and incubated at 27°C for 48 hours. The media was 
collected, centrifuged at 1,000 x g for 15 minutes and the cell pellet was kept for 
analysis. Cell viability was quantitated using trypan blue. 
 
Purification for cryo-EM  
Approximately 300 x 106 transfected SF9 cells were resuspended in 5 ml PBS. The cells 
were centrifuged at 1,000 x g for 15 minute and the supernatant was removed. The cells 
were resuspended in lysis buffer (5 mM MgCl, 2.5 mM KCl, 1.5 mM KH2PO4, 150 mM 
NaCl, 8 mM Na2HPO4, 0.1 mM CaCl2, 1 µg/ml DNase, pH 7.4), then lysed using a parr 
bomb pressurized to 750 psi for 5 min. cell debris was cleared by centrifuging at 500 x 
g for 10 minutes, then membrane fractions were collected by centrifuging at 100,000 x 
g for 30 minutes. The supernatant was aspirated, and the cell pellet transferred to a 
Dounce homogenizer. The pellet was then homogenized into 7 ml lysis buffer (no 
DNase with fresh protease inhibitors). The homogenized membrane fraction was then 
mixed with 7 ml SMA buffer (5 mM MgCl, 2.5 mM KCl, 1.5 mM KH2PO4, 150 mM 
NaCl, 8 mM Na2HPO4, 0.1 mM CaCl2, 3.3 % SMA, pH 7.4) and incubated overnight at 
room temperature with gentle shaking. The sample was then spun at 100,000 x g for 1 
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hour. The supernatant was then applied to Ni-NTA resin in batch format and gently 
rocked at 4°C for 4 hours. The resin was allowed to settle at 1 x g for 20 minutes. The 
resin was then washed three times in 10 ml PBS-Arg buffer and followed by elution in 
2 ml PBS-Arg buffer containing 400 mM imidazole. The eluate was fractionated using 
a superdex 6 10/200 gel filtration column (GE) and the fractions containing the 
complex were combined and concentrated using spin columns (Amicon). 
 
Cryo-EM imaging 
The purified KAR-Neto2 complex at approximately 0.3 mg/ml protein were plunge 
frozen on Quantifoil holey grids (Quantifoil Micro Tools GmbH) The grids were 
previously covered with a thin continuous carbon film and glow-discharged for 5 
seconds. Vitrification was performed at 80–90% humidity, 22°C using a Vitrobot (FEI). 
The grids were imaged using a Technai G2 Polara electron microscope (FEI) operated 
at 200 kV using a K2 Summit direct electron detector camera (Gatan). 
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